[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 74 of about 74
1. Chang SM, Yan ST, Wei CK, Lin CW, Tseng CE: Solitary concomitant endocrine tumor and ductal adenocarcinoma of pancreas. World J Gastroenterol; 2010 Jun 7;16(21):2692-7
Hazardous Substances Data Bank. GLUCAGON .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solitary concomitant endocrine tumor and ductal adenocarcinoma of pancreas.
  • Pancreatic tumors with combined exocrine and endocrine features are rare.
  • Most reported cases are classified as mixed exocrine and endocrine carcinoma of the pancreas.
  • We report the first case of solitary concomitant endocrine tumor and ductal adenocarcinoma of the pancreas.
  • On microscopic examination, the tumor contained both endocrine and exocrine components distinctly separated by the central fibrous band.
  • The exocrine part showed a poorly-differentiated adenocarcinoma.
  • The endocrine part was strongly immunoreactive to chromogranin, synaptophysin and glucagon.
  • We reviewed the literature on pancreatic tumors with combined exocrine and endocrine features.
  • [MeSH-major] Adenocarcinoma / pathology. Carcinoma, Pancreatic Ductal / pathology. Endocrine Gland Neoplasms / pathology. Pancreatic Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] West J Med. 1986 Jun;144(6):746-9 [3014756.001]
  • [Cites] Cancer. 1984 Nov 1;54(9):1766-70 [6089999.001]
  • [Cites] J Gastroenterol. 1997 Aug;32(4):562-5 [9250909.001]
  • [Cites] Int J Pancreatol. 1999 Apr;25(2):77-87 [10360219.001]
  • [Cites] Virchows Arch. 2004 Sep;445(3):231-5 [15517367.001]
  • [Cites] Pancreas. 2005 Jul;31(1):79-83 [15968252.001]
  • [Cites] JOP. 2005 Sep;6(5):449-54 [16186667.001]
  • [Cites] Pancreatology. 2006;6(6):520-6 [17124434.001]
  • [Cites] Gastroenterology. 2008 Apr;134(4):981-7 [18395079.001]
  • [Cites] Arch Pathol Lab Med. 2000 Feb;124(2):284-6 [10656740.001]
  • [Cites] Int J Pancreatol. 2000 Jun;27(3):249-57 [10952408.001]
  • [Cites] Surg Today. 2001;31(2):177-9 [11291717.001]
  • [Cites] Histopathology. 2002 Aug;41(2):122-6 [12147089.001]
  • [Cites] Hepatobiliary Pancreat Dis Int. 2004 Aug;3(3):473-5 [15313692.001]
  • [Cites] Hum Pathol. 1982 Mar;13(3):263-71 [7076209.001]
  • [Cites] J Korean Med Sci. 1996 Apr;11(2):188-92 [8835769.001]
  • (PMID = 20518094.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Chromogranin A; 0 / Hypoglycemic Agents; 0 / Synaptophysin; 9007-92-5 / Glucagon
  • [Other-IDs] NLM/ PMC2880785
  •  go-up   go-down


2. Morales A, Morimoto S, Díaz L, Robles G, Díaz-Sánchez V: Endocrine gland-derived vascular endothelial growth factor in rat pancreas: genetic expression and testosterone regulation. J Endocrinol; 2008 May;197(2):309-14
Hazardous Substances Data Bank. TESTOSTERONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endocrine gland-derived vascular endothelial growth factor in rat pancreas: genetic expression and testosterone regulation.
  • Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) is an endothelial cell mitogen, expressed essentially in steroidogenic cells.
  • Recently, the expression of EG-VEGF in normal human pancreas and pancreatic adenocarcinoma has been demonstrated.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18434360.001).
  • [ISSN] 1479-6805
  • [Journal-full-title] The Journal of endocrinology
  • [ISO-abbreviation] J. Endocrinol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / Vascular Endothelial Growth Factor A; 3XMK78S47O / Testosterone
  •  go-up   go-down


3. Tarakji B, Nassani MZ, Sloan P: Immunohistochemical expression of estrogens and progesterone receptors in carcinoma ex pleomorphic adenoma-undifferentiated and adenocarcinoma types. Med Oral Patol Oral Cir Bucal; 2010 May;15(3):e432-6
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunohistochemical expression of estrogens and progesterone receptors in carcinoma ex pleomorphic adenoma-undifferentiated and adenocarcinoma types.
  • Cancer of the salivary gland is one of the common cancers in the head and the neck regions.
  • Morphologic mimicry and similarity in the expression of steroid hormone receptors between salivary gland tumours and breast tumours are well-known phenomena and are occasionally debated in the field of surgical pathology.
  • Previous studies of the expression of estrogens and progesterone receptors in salivary gland tumours have reported conflicting results.
  • STUDY DESIGN: 27 cases of carcinoma arising in pleomorphic adenoma (undifferentiated and adenocarcinoma types) were examined.
  • CONCLUSION: Our data suggest that carcinomas arising in pleomorphic adenoma were not dependent on endocrine function.
  • [MeSH-major] Adenocarcinoma / metabolism. Adenoma, Pleomorphic / metabolism. Neoplasms, Multiple Primary / metabolism. Receptors, Estrogen / biosynthesis. Receptors, Progesterone / biosynthesis. Salivary Gland Neoplasms / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20038908.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Receptors, Estrogen; 0 / Receptors, Progesterone
  •  go-up   go-down


Advertisement
4. Haghpanah V, Soliemanpour B, Heshmat R, Mosavi-Jarrahi AR, Tavangar SM, Malekzadeh R, Larijani B: Endocrine cancer in Iran: based on cancer registry system. Indian J Cancer; 2006 Apr-Jun;43(2):80-5
Hazardous Substances Data Bank. IODINE, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endocrine cancer in Iran: based on cancer registry system.
  • BACKGROUND: A population-based registry of endocrine cancer cases in four Iranian provinces, was performed for the years 1996-2000.
  • RESULTS: A total of 319 cases of primary endocrine cancer were found and registered, including 313 cases of thyroid carcinoma and 6 cases of adrenal cancer.
  • [MeSH-major] Endocrine Gland Neoplasms / epidemiology. Endocrine Gland Neoplasms / pathology. Registries / statistics & numerical data
  • [MeSH-minor] Adenocarcinoma, Follicular / epidemiology. Adenocarcinoma, Follicular / pathology. Adolescent. Adrenal Gland Neoplasms / epidemiology. Adrenal Gland Neoplasms / pathology. Adult. Age Distribution. Aged. Carcinoma, Medullary / epidemiology. Carcinoma, Medullary / pathology. Carcinoma, Papillary. Child. Child, Preschool. Female. Humans. Incidence. Infant. Infant, Newborn. Iodine / metabolism. Iran / epidemiology. Male. Middle Aged. Pheochromocytoma / epidemiology. Pheochromocytoma / pathology. Retrospective Studies. Sex Distribution. Thyroid Neoplasms / epidemiology. Thyroid Neoplasms / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16790945.001).
  • [ISSN] 0019-509X
  • [Journal-full-title] Indian journal of cancer
  • [ISO-abbreviation] Indian J Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Chemical-registry-number] 9679TC07X4 / Iodine
  •  go-up   go-down


5. Morales A, Vilchis F, Chávez B, Chan C, Robles-Díaz G, Díaz-Sánchez V: Expression and localization of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in human pancreas and pancreatic adenocarcinoma. J Steroid Biochem Mol Biol; 2007 Oct;107(1-2):37-41
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression and localization of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in human pancreas and pancreatic adenocarcinoma.
  • Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) was recently identified as the first tissue-specific angiogenic molecule.
  • Since the human pancreatic cells retain steroidogenic activity, in the present study we ascertained whether this angiogenic factor is expressed in normal pancreas and pancreatic adenocarcinoma.
  • The relative amount of EG-VEGF mRNA in pancreas was more abundant in female adenocarcinoma (0.89) followed by male adenocarcinoma (0.71), than normal female (0.64) and normal male (0.38).
  • The significance of this finding could be interpreted as either, EG-VEGF is not exclusive of endocrine organs, or the pancreas should be considered as a functional steroidogenic tissue.
  • [MeSH-major] Adenocarcinoma / metabolism. Gastrointestinal Hormones / metabolism. Pancreas / metabolism. Pancreatic Neoplasms / metabolism. RNA, Messenger / metabolism. Vascular Endothelial Growth Factor, Endocrine-Gland-Derived / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17683928.001).
  • [ISSN] 0960-0760
  • [Journal-full-title] The Journal of steroid biochemistry and molecular biology
  • [ISO-abbreviation] J. Steroid Biochem. Mol. Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Gastrointestinal Hormones; 0 / PROK1 protein, human; 0 / RNA, Messenger; 0 / Vascular Endothelial Growth Factor, Endocrine-Gland-Derived
  •  go-up   go-down


6. Emanuel PO, de Vinck D, Waldorf HA, Phelps RG: Recurrent endocrine mucin-producing sweat gland carcinoma. Ann Diagn Pathol; 2007 Dec;11(6):448-52
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent endocrine mucin-producing sweat gland carcinoma.
  • Endocrine mucin-producing sweat gland carcinoma is a rare skin tumor that most commonly involves the eyelid of elderly women.
  • Morphologically and immunohistochemically, it is analogous to endocrine ductal carcinoma in situ of the breast and mammary solid papillary carcinoma; also, like the analogous breast lesion, there is an often associated invasive mucinous carcinoma with neuroendocrine differentiation.
  • We describe the case of a 65-year-old woman with endocrine mucin-producing sweat gland carcinoma of the eyelid that recurred 3 years after an apparently complete excision.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Eyelid Neoplasms / pathology. Mucins / biosynthesis. Neoplasm Recurrence, Local / pathology. Sweat Gland Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18022131.001).
  • [ISSN] 1092-9134
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Mucins
  •  go-up   go-down


7. Mehta S, Thiagalingam S, Zembowicz A, Hatton MP: Endocrine mucin-producing sweat gland carcinoma of the eyelid. Ophthal Plast Reconstr Surg; 2008 Mar-Apr;24(2):164-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endocrine mucin-producing sweat gland carcinoma of the eyelid.
  • The lesion was excised and pathology showed it to be endocrine mucin-producing sweat gland carcinoma with positive margins.
  • Clinicians should be aware of this entity given its association with invasive mucinous adenocarcinoma, a locally aggressive tumor with metastatic potential.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Eyelid Neoplasms / pathology. Sweat Gland Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18356733.001).
  • [ISSN] 0740-9303
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chromogranins
  •  go-up   go-down


8. Youn JC, Rhee Y, Park SY, Kim WH, Kim SJ, Chung HC, Hong SW, Lim SK: Severe hypothyroidism induced by thyroid metastasis of colon adenocarcinoma: a case report and review of the literature. Endocr J; 2006 Jun;53(3):339-43
Hazardous Substances Data Bank. LEVOTHYROXINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Severe hypothyroidism induced by thyroid metastasis of colon adenocarcinoma: a case report and review of the literature.
  • Core biopsy of the thyroid gland showed invasion of poorly differentiated adenocarcinoma cells.
  • From these findings and the clinical observations, thyroid metastasis with hypothyroidism developing acutely from metastatic colon adenocarcinoma was diagnosed.
  • [MeSH-major] Adenocarcinoma / secondary. Colonic Neoplasms / pathology. Hypothyroidism / etiology. Thyroid Neoplasms / complications. Thyroid Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Hypothyroidism.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16714841.001).
  • [ISSN] 0918-8959
  • [Journal-full-title] Endocrine journal
  • [ISO-abbreviation] Endocr. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 9002-71-5 / Thyrotropin; Q51BO43MG4 / Thyroxine
  •  go-up   go-down


9. Tannous ZS, Avram MM, Zembowicz A, Mihm MC, Liteplo M, Kwan T, Olbricht SM: Treatment of synchronous mucinous carcinoma and endocrine mucin-producing sweat gland carcinoma with Mohs' micrographic surgery. Dermatol Surg; 2005 Mar;31(3):364-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment of synchronous mucinous carcinoma and endocrine mucin-producing sweat gland carcinoma with Mohs' micrographic surgery.
  • BACKGROUND: Endocrine mucin-producing sweat gland carcinoma is a very rare cutaneous tumor that has been reported only in three patients previously.
  • We report a case of an endocrine mucin-producing sweat gland carcinoma associated with mucinous carcinoma treated by Mohs' micrographic surgery.
  • METHODS: A 79-year-old female with a 2-year history of four lesions of biopsy-proven endocrine mucin-producing sweat gland carcinomas and mucinous carcinoma was treated with Mohs' micrographic surgery.
  • CONCLUSION: Mohs' micrographic surgery is an appropriate treatment for mucinous carcinomata, including endocrine mucin-producing sweat gland carcinoma and mucinous carcinoma.
  • [MeSH-major] Adenocarcinoma, Mucinous / surgery. Mohs Surgery. Neoplasms, Multiple Primary / surgery. Orbital Neoplasms / surgery. Sweat Gland Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15841644.001).
  • [ISSN] 1076-0512
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. Singh R, Basturk O, Klimstra DS, Zamboni G, Chetty R, Hussain S, La Rosa S, Yilmaz A, Capelli P, Capella C, Cheng JD, Adsay NV: Lipid-rich variant of pancreatic endocrine neoplasms. Am J Surg Pathol; 2006 Feb;30(2):194-200
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lipid-rich variant of pancreatic endocrine neoplasms.
  • Most pancreatic endocrine neoplasms (PENs) show characteristic and well-recognized endocrine morphology; however, a lipid-rich pattern, which can present a diagnostic problem in biopsies, has been reported, mostly as individual cases.
  • In some cases, the nuclei were distorted by the vesicles, and the usual endocrine chromatin pattern was not evident.
  • Pathology reports indicated substantial diagnostic challenge in these cases; on biopsies, 1 case was originally diagnosed as adrenal cortical carcinoma, another as renal cell carcinoma, a third as solid-pseudopapillary tumor, and a fourth had a fine needle aspiration cytologic diagnosis of adenocarcinoma.
  • [MeSH-major] Endocrine Gland Neoplasms / pathology. Lipids. Pancreatic Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Adrenocortical Carcinoma / pathology. Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Carcinoma, Renal Cell / pathology. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Male. Microscopy, Electron, Transmission. Middle Aged. Multiple Endocrine Neoplasia Type 1 / pathology. von Hippel-Lindau Disease / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16434893.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Lipids
  •  go-up   go-down


11. Zembowicz A, Garcia CF, Tannous ZS, Mihm MC, Koerner F, Pilch BZ: Endocrine mucin-producing sweat gland carcinoma: twelve new cases suggest that it is a precursor of some invasive mucinous carcinomas. Am J Surg Pathol; 2005 Oct;29(10):1330-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endocrine mucin-producing sweat gland carcinoma: twelve new cases suggest that it is a precursor of some invasive mucinous carcinomas.
  • Endocrine mucin-producing sweat gland carcinoma (EMPSGC) is an underrecognized low-grade carcinoma with predilection to the eyelid.
  • The series provides histologic evidence for a multistage progression of noninvasive sweat gland neuroendocrine carcinoma to EMPSGC and then to mucinous carcinoma of the eyelid.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Sweat Gland Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16160476.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


12. Volante M, Rindi G, Papotti M: The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrine-endocrine neoplasms. Virchows Arch; 2006 Nov;449(5):499-506

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrine-endocrine neoplasms.
  • Terms such as "mixed endocrine-exocrine carcinoma" (MEEC) and "adenocarcinoma with neuroendocrine (NE) differentiation" (ADC-NE) identify tumours belonging to the spectrum of neoplasms with divergent exocrine and (neuro)endocrine differentiation.
  • Conversely, ADC-NE generally do not show a different clinical outcome, compared to the corresponding conventional forms, except for prostatic adenocarcinoma, in which NE cells are a negative prognostic factor.
  • [MeSH-major] Endocrine Gland Neoplasms / pathology. Neuroendocrine Tumors / pathology. Neurosecretory Systems / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Cell Differentiation. Chromogranin A / analysis. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17033797.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Chromogranin A
  • [Number-of-references] 59
  •  go-up   go-down


13. Nakano S, Shomura H, Akabane H, Inagaki M, Yanagida N: [Two cases of gastric endocrine cell carcinoma]. Gan To Kagaku Ryoho; 2010 Nov;37(12):2505-7
Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Two cases of gastric endocrine cell carcinoma].
  • Gastric endocrine cell carcinoma is rare and associated with a poor prognosis.
  • The first case was a man in his sixties with gastric endocrine cell carcinoma, of which a clinical finding was T2N1M0H1 (Stage IV).
  • But the tumor was re-grown and the patient died twenty months after diagnosis.
  • The second case was a man in his seventies with gastric endocrine cell carcinoma, of which a clinical finding was T3N1M0H0P0, Stage IIIa, underwent total gastrectomy.
  • [MeSH-major] Endocrine Gland Neoplasms / pathology. Stomach Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / therapy. Aged. Antineoplastic Agents / administration & dosage. Antineoplastic Agents, Phytogenic / administration & dosage. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Camptothecin / administration & dosage. Camptothecin / analogs & derivatives. Cisplatin / administration & dosage. Drug Combinations. Humans. Male. Middle Aged. Oxonic Acid / administration & dosage. Tegafur / administration & dosage

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21224621.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Antineoplastic Agents, Phytogenic; 0 / Drug Combinations; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 5VT6420TIG / Oxonic Acid; 7673326042 / irinotecan; Q20Q21Q62J / Cisplatin; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


14. Jiang X, Abiatari I, Kong B, Erkan M, De Oliveira T, Giese NA, Michalski CW, Friess H, Kleeff J: Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in pancreatic cancer. Pancreatology; 2009;9(1-2):165-72
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in pancreatic cancer.
  • AIMS: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticins have been identified as tissue-specific angiogenic factors.
  • RESULTS: QRT-PCR analysis in bulk tissues of normal pancreas, chronic pancreatitis and pancreatic ductal adenocarcinoma showed no significant difference of PK1 mRNA levels, whereas PK2 mRNA was barely detectable.
  • [MeSH-major] Islets of Langerhans / metabolism. Pancreas / metabolism. Pancreatic Neoplasms / metabolism. Vascular Endothelial Growth Factor, Endocrine-Gland-Derived / biosynthesis

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • Genetic Alliance. consumer health - Pancreatic cancer 1.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2008 S. Karger AG, Basel and IAP.
  • (PMID = 19077468.001).
  • [ISSN] 1424-3911
  • [Journal-full-title] Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
  • [ISO-abbreviation] Pancreatology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Gastrointestinal Hormones; 0 / Neuropeptides; 0 / PROK2 protein, human; 0 / PROKR1 protein, human; 0 / PROKR2 protein, human; 0 / RNA, Messenger; 0 / Receptors, G-Protein-Coupled; 0 / Receptors, Peptide; 0 / Vascular Endothelial Growth Factor, Endocrine-Gland-Derived
  •  go-up   go-down


15. Jain D, Eslami-Varzaneh F, Takano AM, Ayer U, Umashankar R, Muller R, Klimstra DS: Composite glandular and endocrine tumors of the stomach with pancreatic acinar differentiation. Am J Surg Pathol; 2005 Nov;29(11):1524-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Composite glandular and endocrine tumors of the stomach with pancreatic acinar differentiation.
  • Composite tumors of the stomach consisting of mixed glandular and endocrine components are rare.
  • We report 3 cases of composite glandular and endocrine tumors with pancreatic acinar differentiation in the stomach with their clinicopathologic findings.
  • They showed admixture of well-differentiated endocrine components with acinar and glandular components.
  • The glandular component consisted of columnar epithelial cells resembling gastric foveolar or intestinal goblet cells, consistent with a well-differentiated adenocarcinoma.
  • While the immunoreactivity for cytokeratin 7, cytokeratin 20, Muc2, Muc5AC, and CEA was largely restricted to the glandular component, the endocrine and pancreatic acinar markers showed marked variability and overlap.
  • All cases showed immunoreactivity for at least one of the exocrine pancreatic enzymes, and all expressed endocrine differentiation.
  • In summary, these tumors represent another distinct type of composite glandular and endocrine gastric neoplasm with pancreatic acinar differentiation.
  • [MeSH-major] Adenocarcinoma / pathology. Endocrine Gland Neoplasms / pathology. Neoplasms, Glandular and Epithelial / pathology. Pancreas, Exocrine / pathology. Stomach Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16224221.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


16. Zissis D, Zizi-Serbetzoglou A, Grammatoglou X, Glava C, Katsamagkou E, Nikolaidou ME, Vasilakaki T: Combined carcinoid and mixed (composite) glandular - endocrine cell carcinoma of the stomach in atrophic gastritis. J BUON; 2009 Jan-Mar;14(1):127-30
MedlinePlus Health Information. consumer health - Stomach Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined carcinoid and mixed (composite) glandular - endocrine cell carcinoma of the stomach in atrophic gastritis.
  • We describe a case of gastric carcinoid and inflammatory fibroid polyp concomitant with a composite tumor of the gastric antrum composed of poorly differentiated adenocarcinoma - endocrine carcinoma with immunohistochemical documentation of endocrine and non endocrine differentiation in a 67-year-old man with atrophic gastritis and intestinal metaplasia.
  • The same occurrence is reported in several cases in the literature, which suggests that the association of gastric carcinoid to adenocarcinoma could point to the malignant nature of carcinoid.
  • [MeSH-major] Adenocarcinoma / pathology. Carcinoid Tumor / pathology. Endocrine Gland Neoplasms / pathology. Gastritis, Atrophic / pathology. Polyps / pathology. Precancerous Conditions / pathology. Stomach Neoplasms / pathology

  • Genetic Alliance. consumer health - Stomach carcinoma.
  • MedlinePlus Health Information. consumer health - Carcinoid Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19365883.001).
  • [ISSN] 1107-0625
  • [Journal-full-title] Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • [ISO-abbreviation] J BUON
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


17. Bulliard C, Murali R, Maloof A, Adams S: Endocrine mucin-producing sweat gland carcinoma: report of a case and review of the literature. J Cutan Pathol; 2006 Dec;33(12):812-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endocrine mucin-producing sweat gland carcinoma: report of a case and review of the literature.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Eyelid Neoplasms / pathology. Sweat Gland Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17177942.001).
  • [ISSN] 0303-6987
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


18. Villeneuve DL, Ankley GT, Makynen EA, Blake LS, Greene KJ, Higley EB, Newsted JL, Giesy JP, Hecker M: Comparison of fathead minnow ovary explant and H295R cell-based steroidogenesis assays for identifying endocrine-active chemicals. Ecotoxicol Environ Saf; 2007 Sep;68(1):20-32
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of fathead minnow ovary explant and H295R cell-based steroidogenesis assays for identifying endocrine-active chemicals.
  • An in vitro steroidogenesis assay using H295R human adenocarcinoma cells has been suggested as a possible alternative to gonad explant assays for use as a Tier I screening assay to detect endocrine active chemicals capable of modulating steroid hormone synthesis.
  • Overall, however, results of this study suggest that both the H295R and fathead minnow ovary explant assays have utility for identifying endocrine-active chemicals in screening-type applications.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adrenal Gland Neoplasms / drug therapy. Cyprinidae. Estradiol / biosynthesis. Hormone Antagonists / toxicity. Ovary / drug effects. Testosterone / biosynthesis

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. ESTRADIOL .
  • Hazardous Substances Data Bank. TESTOSTERONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17449096.001).
  • [ISSN] 0147-6513
  • [Journal-full-title] Ecotoxicology and environmental safety
  • [ISO-abbreviation] Ecotoxicol. Environ. Saf.
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Hormone Antagonists; 3XMK78S47O / Testosterone; 4TI98Z838E / Estradiol
  •  go-up   go-down


19. Norimura D, Mizuta Y, Oohara H, Okamoto K, Hayashi H, Matuo T, Nakagoe T, Isomoto H, Shikuwa S, Kohno S: [A case of endocrine carcinoma of the sigmoid colon]. Nihon Shokakibyo Gakkai Zasshi; 2008 Feb;105(2):228-34

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of endocrine carcinoma of the sigmoid colon].
  • We report a case of endocrine carcinoma of the sigmoid colon.
  • He was given a diagnosis of the poorly differentiated adenocarcinoma of the colon, and underwent sigmoidectomy with dissection of the lymph nodes.
  • Histological and immunohistochemical examinations of the resected specimen revealed endocrine carcinoma.
  • Endocrine carcinoma of the colon is rare, and the prognosis is very poor.
  • [MeSH-major] Endocrine Gland Neoplasms / pathology. Sigmoid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18250594.001).
  • [ISSN] 0446-6586
  • [Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
  • [ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


20. Ishida M, Katsura K, Nagata A, Kijima K, Kushima R, Okabe H: [A case of primary mucinous carcinoma with endocrine differentiation of the skin]. Rinsho Byori; 2008 Jun;56(6):455-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of primary mucinous carcinoma with endocrine differentiation of the skin].
  • Primary mucinous carcinoma of the skin (MCS) is a rare skin appendage tumor and only a few cases of MCS with endocrine differentiation have been reported.
  • Here we report an additional case of primary pure MCS with endocrine differentiation arising in the face.
  • There was no tumor in the other organs and synaptophysin and chromogranin A were sporadically shown immunohistochemically in the tumor cells; a diagnosis of primary pure MCS with endocrine differentiation was made.
  • It is presumed that MCS is derived from the apocrine gland, which is closely related to the mammary gland.
  • Although endocrine differentiation is not uncommon in pure mucinous carcinoma of the breast, there have been only a few reports published on endocrine differentiation in MCS.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Facial Neoplasms / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18646630.001).
  • [ISSN] 0047-1860
  • [Journal-full-title] Rinsho byori. The Japanese journal of clinical pathology
  • [ISO-abbreviation] Rinsho Byori
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


21. Marsh WL, Colonna J, Yearsley M, Bloomston M, Frankel WL: Calponin is expressed in serous cystadenomas of the pancreas but not in adenocarcinomas or endocrine tumors. Appl Immunohistochem Mol Morphol; 2009 May;17(3):216-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Calponin is expressed in serous cystadenomas of the pancreas but not in adenocarcinomas or endocrine tumors.
  • The diagnosis of serous microcystic adenoma (SMA) is usually straightforward.
  • For small biopsies and/or unusual variants, the differential diagnosis includes other pancreatic or metastatic neoplasms showing cystic or clear cell features.
  • We evaluated immunostains for potential use in the diagnosis of SMA.
  • Additionally, microarrays previously constructed from 56 pancreatic adenocarcinomas (PACs) and 64 pancreatic endocrine tumors (PENs) were studied.
  • An immunohistochemical profile of staining with calponin, alpha-inhibin, and m-NSE and absent staining with chromogranin supports the diagnosis of SMA, and distinguishes SMA from PAC and PEN.
  • Calponin and alpha-inhibin are the most useful positive markers for SMA, and are negative in most entities in the differential diagnosis.

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19391217.001).
  • [ISSN] 1533-4058
  • [Journal-full-title] Applied immunohistochemistry & molecular morphology : AIMM
  • [ISO-abbreviation] Appl. Immunohistochem. Mol. Morphol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Calcium-Binding Proteins; 0 / Microfilament Proteins; 0 / calponin; 0 / inhibin-alpha subunit; 57285-09-3 / Inhibins; EC 4.2.1.11 / Phosphopyruvate Hydratase
  •  go-up   go-down


22. Marrache F, Cazals-Hatem D, Kianmanesh R, Palazzo L, Couvelard A, O'Toole D, Maire F, Hammel P, Levy P, Sauvanet A, Ruszniewski P: Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: a fortuitous association? Pancreas; 2005 Jul;31(1):79-83
Hazardous Substances Data Bank. GLUCAGON .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: a fortuitous association?
  • OBJECTIVES: Pancreatic endocrine tumors (PETs) and intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are rare diseases of the pancreas.
  • Cases of association of endocrine and exocrine neoplasms of the pancreas have been reported, corresponding to mixed or amphicrine tumors.
  • RESULTS: Preoperative diagnosis was unspecified pancreatic tumor (n = 1), IPMN (n = 2), and association of PET and IPMN (n = 3).
  • CONCLUSION: This study describes a new aspect of endocrine-exocrine pancreatic neoplasm association.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Carcinoma, Pancreatic Ductal / pathology. Carcinoma, Papillary / pathology. Endocrine Gland Neoplasms / pathology. Pancreatic Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15968252.001).
  • [ISSN] 1536-4828
  • [Journal-full-title] Pancreas
  • [ISO-abbreviation] Pancreas
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chromogranin A; 0 / Chromogranins; 9007-92-5 / Glucagon
  •  go-up   go-down


23. Bibeau F, Chateau MC, Guiu M, Assenat E, Azria D, Lavaill R, Ychou M, Boissière-Michot F: Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett's oesophagus: report of a case with a favourable behaviour. Virchows Arch; 2008 Jan;452(1):103-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett's oesophagus: report of a case with a favourable behaviour.
  • They are rarely combined with another type of malignancy, such as endocrine tumours.
  • Within the endocrine spectrum, small cell carcinomas (SmCC) usually have a highly aggressive behaviour with a poor prognosis.
  • We report a case of composite SmCC and adenocarcinoma in the setting of a Barrett's oesophagus, in a 54-year-old man.
  • The adenocarcinoma component showed a converse phenotype.
  • In our case, the origin of the SmCC component could be explained by the numerous chromogranin A-positive cells observed in the Barrett's oesophagus or by the potential progenitor cells that may be located in the submucosal oesophageal gland ducts and the Barrett's metaplasia.
  • [MeSH-major] Adenocarcinoma / pathology. Barrett Esophagus / pathology. Carcinoma, Small Cell / pathology. Esophageal Neoplasms / pathology. Neoplasms, Multiple Primary

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18008084.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Chromogranin A
  •  go-up   go-down


24. Romanchishen AF, Iakovlev PN: [Special surgical treatment of patients with nodular tumors of the thyroid gland against the background of diffuse toxic goiter]. Vestn Khir Im I I Grek; 2005;164(1):21-4
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Special surgical treatment of patients with nodular tumors of the thyroid gland against the background of diffuse toxic goiter].
  • The authors have analyzed the results of treatment of 147 patients with diffuse toxic goiter (DTG) operated upon in the St. Petersburg Center of the surgery of the endocrine system organs.
  • It was shown that the presence of nodules in the thyroid gland did not influence the nearest and distant results when using the corresponding surgical strategy.
  • [MeSH-major] Adenocarcinoma, Follicular / surgery. Adenoma / surgery. Carcinoma, Papillary / surgery. Graves Disease / complications. Thyroid Neoplasms / surgery
  • [MeSH-minor] Adult. Age Factors. Aged. Female. Follow-Up Studies. Humans. Male. Middle Aged. Postoperative Complications. Sex Factors. Thyroid Gland / pathology. Thyroidectomy. Time Factors. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15957803.001).
  • [ISSN] 0042-4625
  • [Journal-full-title] Vestnik khirurgii imeni I. I. Grekova
  • [ISO-abbreviation] Vestn. Khir. Im. I. I. Grek.
  • [Language] rus
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


25. Delellis RA: Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma. Endocr Pathol; 2008;19(4):221-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma.
  • While the diagnosis of adenomas is usually straightforward, parathyroid carcinomas (PTCAs) often present considerable diagnostic challenges.
  • An unequivocal diagnosis of PTCA should be restricted to those tumors that invade adjacent soft tissues, thyroid gland, blood vessels, or perineural spaces or to those cases with documented metastases.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenoma / diagnosis. Parathyroid Neoplasms / diagnosis
  • [MeSH-minor] Biomarkers, Tumor / analysis. Cell Nucleus / chemistry. Cell Nucleus / pathology. Diagnosis, Differential. Humans. Immunohistochemistry. Mutation. Neoplasm Invasiveness. Tumor Suppressor Proteins / analysis. Tumor Suppressor Proteins / genetics. Tumor Suppressor Proteins / metabolism

  • Genetic Alliance. consumer health - Parathyroid carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19058032.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CDC73 protein, human; 0 / Tumor Suppressor Proteins
  • [Number-of-references] 35
  •  go-up   go-down


26. Puente S, Velasco A, Gallel P, Pallares J, Perez-Ruiz L, Ros S, Maravall J, Matias-Guiu X: Metastatic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder. Endocr Pathol; 2008;19(3):190-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder.
  • Small cell carcinomas may occur in the thyroid gland.
  • However, the vast majority of small cell carcinomas involving the thyroid gland are metastatic tumors.
  • [MeSH-minor] Adenocarcinoma / pathology. Base Sequence. Carcinoma, Transitional Cell / pathology. DNA Methylation. DNA Mutational Analysis. Humans. Immunohistochemistry. Loss of Heterozygosity. Male. Middle Aged. Neoplasms, Multiple Primary / pathology. Promoter Regions, Genetic / genetics. Prostatic Neoplasms / pathology. Tumor Suppressor Protein p53 / genetics. Tumor Suppressor Proteins / genetics

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18446450.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RASSF1 protein, human; 0 / Tumor Suppressor Protein p53; 0 / Tumor Suppressor Proteins
  •  go-up   go-down


27. Lepage C, Bouvier AM, Manfredi S, Dancourt V, Faivre J: Incidence and management of primary malignant small bowel cancers: a well-defined French population study. Am J Gastroenterol; 2006 Dec;101(12):2826-32
MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Treatment and stage at diagnosis were investigated.
  • There were four main histological types: adenocarcinoma (40.4%), malignant endocrine tumors (30.5%), lymphoma (20.1%), and sarcoma (9.0%).
  • It varied between 56.8% for endocrine tumors and 17.8% for sarcoma.
  • In the multivariate analysis, age, histology, and stage at diagnosis significantly influenced the prognosis.
  • [MeSH-major] Adenocarcinoma / epidemiology. Endocrine Gland Neoplasms / epidemiology. Intestinal Neoplasms / epidemiology. Intestine, Small. Lymphoma / epidemiology. Sarcoma / epidemiology

  • MedlinePlus Health Information. consumer health - Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17026561.001).
  • [ISSN] 0002-9270
  • [Journal-full-title] The American journal of gastroenterology
  • [ISO-abbreviation] Am. J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


28. Mulkeen AL, Yoo PS, Cha C: Less common neoplasms of the pancreas. World J Gastroenterol; 2006 May 28;12(20):3180-5
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recently, there has been an increased recognition of neoplasms of the pancreas other than ductal adenocarcinoma.
  • Although not as well studied or characterized as pancreatic adenocarcinoma there are many distinct lesions which exhibit diverse biological behaviors and varying degrees of malignancy.
  • These lesions include: endocrine neoplasms, cystic tumors, solid pseudopapillary tumors, acinar cell carcinoma, squamous cell carcinoma, primary lymphoma of the pancreas, and metastatic lesions to the pancreas.
  • This review article discusses the clinical course, diagnosis, and treatment of these less common, but quite relevant, neoplasms of the pancreas.
  • [MeSH-major] Pancreatic Neoplasms / diagnosis. Pancreatic Neoplasms / therapy
  • [MeSH-minor] Adenocarcinoma, Mucinous / diagnosis. Adenocarcinoma, Mucinous / therapy. Carcinoma, Acinar Cell / diagnosis. Carcinoma, Acinar Cell / therapy. Carcinoma, Papillary / diagnosis. Carcinoma, Papillary / therapy. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / therapy. Cystadenoma, Mucinous / diagnosis. Cystadenoma, Mucinous / therapy. Cystadenoma, Serous / diagnosis. Cystadenoma, Serous / therapy. Endocrine Gland Neoplasms / diagnosis. Endocrine Gland Neoplasms / therapy. Humans. Lymphoma / diagnosis. Lymphoma / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Pathol. 2002 Apr;160(4):1361-9 [11943721.001]
  • [Cites] Am J Pathol. 2002 Mar;160(3):953-62 [11891193.001]
  • [Cites] Ann Surg Oncol. 2002 Aug;9(7):675-9 [12167582.001]
  • [Cites] N Engl J Med. 2002 Nov 28;347(22):1783-91 [12456855.001]
  • [Cites] J Clin Oncol. 2002 Dec 15;20(24):4673-8 [12488412.001]
  • [Cites] J Clin Gastroenterol. 2003 Mar;36(3):261-5 [12590239.001]
  • [Cites] J Am Coll Surg. 2005 Jun;200(6):965-72 [15922212.001]
  • [Cites] Pancreas. 2005 Aug;31(2):182-7 [16025006.001]
  • [Cites] Ann Surg. 2005 Sep;242(3):413-9; discussion 419-21 [16135927.001]
  • [Cites] J Clin Gastroenterol. 2005 Nov-Dec;39(10):915-9 [16208119.001]
  • [Cites] J Clin Oncol. 2005 Jul 10;23(20):4518-23 [16002842.001]
  • [Cites] Leuk Lymphoma. 2003 Jan;44(1):205-7 [12691166.001]
  • [Cites] Pancreas. 2003 Jul;27(1):e18-22 [12826914.001]
  • [Cites] Arch Surg. 2003 Aug;138(8):859-66 [12912744.001]
  • [Cites] Digestion. 2003;68(1):24-33 [12949436.001]
  • [Cites] J Gastrointest Surg. 2003 Dec;7(8):970-7 [14675706.001]
  • [Cites] Endocr Relat Cancer. 2004 Mar;11(1):1-18 [15027882.001]
  • [Cites] Ann Surg. 2004 Mar;239(3):400-8 [15075659.001]
  • [Cites] Ann Surg. 2004 May;239(5):678-85; discussion 685-7 [15082972.001]
  • [Cites] Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9 [15166958.001]
  • [Cites] J Surg Res. 2004 Jul;120(1):139-61 [15172200.001]
  • [Cites] Am J Clin Pathol. 2004 Jun;121(6):898-903 [15198364.001]
  • [Cites] Virchows Arch. 2004 Jun;444(6):527-35 [15057558.001]
  • [Cites] N Engl J Med. 2004 Sep 16;351(12):1218-26 [15371579.001]
  • [Cites] Cancer. 1980 Sep 1;46(5):1192-6 [7214302.001]
  • [Cites] Surgery. 1990 Sep;108(3):475-80 [2396191.001]
  • [Cites] Cancer. 1991 Sep 15;68(6):1329-34 [1678681.001]
  • [Cites] Ann Surg. 1992 Jan;215(1):8-18 [1531004.001]
  • [Cites] Acta Cytol. 1992 Jul-Aug;36(4):471-6 [1636336.001]
  • [Cites] Medicine (Baltimore). 1996 Mar;75(2):53-63 [8606627.001]
  • [Cites] J Gastrointest Surg. 1998 Sep-Oct;2(5):472-82 [9843608.001]
  • [Cites] Surgery. 1998 Dec;124(6):1050-5 [9854582.001]
  • [Cites] Am J Surg Pathol. 1999 Apr;23(4):410-22 [10199470.001]
  • [Cites] Arch Surg. 1999 Oct;134(10):1131-6 [10522860.001]
  • [Cites] Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):872-6 [15523224.001]
  • [Cites] Cancer. 2004 Oct 25;102(5):315-21 [15386314.001]
  • [Cites] AJR Am J Roentgenol. 2005 Feb;184(2):511-9 [15671372.001]
  • [Cites] Am J Surg Pathol. 2005 Apr;29(4):512-9 [15767807.001]
  • [Cites] Pancreas. 2005 Apr;30(3):218-22 [15782097.001]
  • [Cites] Ann Surg Oncol. 2005 Feb;12(2):124-32 [15827792.001]
  • [Cites] Am J Surg. 1999 Oct;178(4):269-74 [10587182.001]
  • [Cites] J Prosthet Dent. 1999 Nov;82(5):512-4 [10559720.001]
  • [Cites] Gastroenterology. 2005 May;128(6):1668-84 [15887158.001]
  • [Cites] J Am Coll Surg. 2000 Apr;190(4):432-45 [10757381.001]
  • [Cites] AJR Am J Roentgenol. 2000 Jul;175(1):99-103 [10882255.001]
  • [Cites] Med Oncol. 2000 Aug;17(3):237-47 [10962538.001]
  • [Cites] Surgery. 2001 Mar;129(3):380-3 [11231470.001]
  • [Cites] Oncology. 2001;60(4):322-9 [11408800.001]
  • [Cites] Front Neuroendocrinol. 2001 Oct;22(4):309-39 [11587555.001]
  • [Cites] Ann Surg Oncol. 2002 Jan-Feb;9(1):35-40 [11833495.001]
  • [Cites] Pancreatology. 2001;1(6):641-7 [12120248.001]
  • (PMID = 16718837.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] China
  • [Number-of-references] 51
  • [Other-IDs] NLM/ PMC4087960
  •  go-up   go-down


29. Albores-Saavedra J, Wu J: The many faces and mimics of papillary thyroid carcinoma. Endocr Pathol; 2006;17(1):1-18
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This article provides an overview of the 15 histologic variants of papillary thyroid carcinoma listed by the 2004 World Health Organization (WHO) monograph on endocrine tumors.
  • The histologic features, differential diagnosis, and clinical course of each variant are discussed in some detail.
  • [MeSH-major] Adenocarcinoma, Papillary / pathology. Thyroid Neoplasms / pathology
  • [MeSH-minor] Adenoma / diagnosis. Cell Nucleus / pathology. Diagnosis, Differential. Hashimoto Disease / diagnosis. Humans. Hyperplasia / diagnosis. Thyroid Gland / pathology. World Health Organization

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16760576.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 68
  •  go-up   go-down


30. Vanbeckevoort D: Solid pancreatic masses: benign or malignant. JBR-BTR; 2007 Nov-Dec;90(6):487-9
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Endocrine tumours represent only a minority of those tumours.
  • While endocrine tumours tend to exhibit symptoms earlier in the course of the disease (due to tumour-related hormone production), adenocarcinomas present in nearly all cases in advanced stages when curative resection is not feasible.
  • [MeSH-major] Adenocarcinoma / diagnosis. Endocrine Gland Neoplasms / diagnosis. Magnetic Resonance Imaging / methods. Pancreatic Neoplasms / diagnosis. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Diagnosis, Differential. Humans

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18376761.001).
  • [ISSN] 0302-7430
  • [Journal-full-title] JBR-BTR : organe de la Société royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)
  • [ISO-abbreviation] JBR-BTR
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Belgium
  • [Number-of-references] 13
  •  go-up   go-down


31. Ito Y, Miyauchi A: Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J; 2009;56(2):177-92
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Differentiated thyroid carcinoma originates from thyroid follicular cells and is the most prominent malignancy of the endocrine organs.
  • Papillary carcinoma frequently metastasizes to the regional lymph node and shows multicentricity in the thyroid gland.
  • [MeSH-major] Carcinoma, Papillary / diagnosis. Carcinoma, Papillary / therapy. Thyroid Neoplasms / diagnosis. Thyroid Neoplasms / therapy
  • [MeSH-minor] Adenocarcinoma, Follicular / diagnosis. Adenocarcinoma, Follicular / pathology. Humans. Japan / epidemiology. Lymphatic Metastasis / pathology. Prognosis. Thyroidectomy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18703852.001).
  • [ISSN] 1348-4540
  • [Journal-full-title] Endocrine journal
  • [ISO-abbreviation] Endocr. J.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 113
  •  go-up   go-down


32. Enomoto K, Sakurai K, Amano S: [Experience of parathyroid cancer which required a differentiation from adenoma]. Gan To Kagaku Ryoho; 2010 Nov;37(12):2325-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We noted a thyroid gland mass by examination and referred for a further checkup.
  • The cervical echography evidence showed a mass image of the border regular in the back of inferior pole of left thyroid gland.
  • It also revealed a mass image with the calcification in the inferior pole of left lobe of thyroid gland at the same time.
  • We performed aspiration biopsy cytology for a thyroid gland mass, and it was class IIIa.
  • We also performed parathyroidectomy and left lobe of thyroid gland ablative surgery because of a diagnosis of the hyperparathyroidism confirmed a primary parathyroid adenoma.
  • Preoperative pathological diagnosis was adenoma.
  • However, histopathology laboratory findings showed it to be of adenocarcinoma of the parathyroid, which metastasized into the thyroid.
  • Many times parathyroid cancer preoperative diagnosis is inconclusive.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenoma / diagnosis. Parathyroid Neoplasms / diagnosis
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Hyperparathyroidism / etiology. Hyperparathyroidism / surgery. Male. Parathyroidectomy. Thyroid Neoplasms / secondary. Thyroidectomy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21224561.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


33. Zivaljevic V, Paunovic I, Diklic A, Krgovic K, Kalezic N, Kazic M, Tatic S, Savic D, Stojanovic D, Perunovic R: The incidence of familial nonmedullary thyroid cancer in a large case series. Acta Chir Belg; 2008 May-Jun;108(3):328-32
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MATERIAL AND METHODS: Data on 1411 patients surgically treated for nonmedullary thyroid carcinoma, in the Center for Endocrine Surgery in Belgrade, from 1995 to 2006 were analysed.
  • The possible presence of malignant tumours of the thyroid gland was investigated in their closest relatives in order to identify cases of FNMTC.
  • RESULTS: Thirteen patients (11 females and 2 males) (0.92% of those with nonmedullary carcinoma of the thyroid gland) had a familial form of the disease.
  • In two of the thirteen cases the tumour penetrated the capsule of the thyroid gland.
  • CONCLUSION: Familial nonmedullary carcinoma of the thyroid gland occurs very rarely.
  • [MeSH-major] Adenocarcinoma, Follicular / epidemiology. Carcinoma / epidemiology. Carcinoma, Papillary / epidemiology. Thyroid Neoplasms / epidemiology

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18710108.001).
  • [ISSN] 0001-5458
  • [Journal-full-title] Acta chirurgica Belgica
  • [ISO-abbreviation] Acta Chir. Belg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


34. Tison C, Regenet N, Meurette G, Mirallié E, Cassagnau E, Frampas E, Le Borgne J: Cystic dystrophy of the duodenal wall developing in heterotopic pancreas: report of 9 cases. Pancreas; 2007 Jan;34(1):152-6
MedlinePlus Health Information. consumer health - Small Intestine Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathological findings in surgical specimens were multiple cysts located in the thickened duodenal wall (n = 9), ectopic pancreatic tissue (n = 7), fibrosis of the normal gland (n = 4), and adenocarcinoma in ectopic tissue (n = 1).
  • In 1 case, the patient died of disseminated adenocarcinoma.
  • CONCLUSION: Endoscopic ultrasonography and magnetic resonance pancreatography are the most useful investigations for the diagnosis of CDHP.
  • [MeSH-minor] Adenocarcinoma / complications. Adult. Aged. Cholangiopancreatography, Magnetic Resonance. Female. Follow-Up Studies. Humans. Intestinal Obstruction / radiography. Intestinal Obstruction / surgery. Intestinal Obstruction / ultrasonography. Male. Middle Aged. Pancreatic Neoplasms / complications. Pancreaticoduodenectomy. Pancreatitis, Alcoholic / complications. Retrospective Studies. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17198198.001).
  • [ISSN] 1536-4828
  • [Journal-full-title] Pancreas
  • [ISO-abbreviation] Pancreas
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


35. Pallante P, Visone R, Croce CM, Fusco A: Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer; 2010 Mar;17(1):F91-104
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Carcinoma of the thyroid gland is an uncommon cancer, but one of the most frequent malignancies of the endocrine system.
  • Here, other than summarizing the current findings on microRNA expression in human thyroid carcinomas, we discuss the mechanisms by which microRNA deregulation may play a role in thyroid carcinogenesis, and the possible use of microRNA knowledge in the diagnosis and therapy of thyroid neoplasms.
  • [MeSH-major] Adenocarcinoma, Follicular / genetics. Cell Transformation, Neoplastic / genetics. Gene Expression Regulation, Neoplastic. MicroRNAs / genetics. RNA, Neoplasm / genetics. Thyroid Neoplasms / genetics
  • [MeSH-minor] Animals. Biomarkers, Tumor / analysis. Carcinoma / diagnosis. Carcinoma, Papillary / diagnosis. Diagnosis, Differential. Gene Expression Profiling. Humans. Mice. Mice, Transgenic. Mutation. Neoplasms, Radiation-Induced / diagnosis. Neoplasms, Radiation-Induced / genetics. Neoplasms, Radiation-Induced / pathology. Oligonucleotide Array Sequence Analysis. Oncogenes

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19942715.001).
  • [ISSN] 1479-6821
  • [Journal-full-title] Endocrine-related cancer
  • [ISO-abbreviation] Endocr. Relat. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / MicroRNAs; 0 / RNA, Neoplasm
  • [Number-of-references] 106
  •  go-up   go-down


36. Lachinski AJ, Stefaniak T, Kobiela J, Connor S, Gruca Z, Sledzinski Z: New prognostic scales LAST-1 and LAST-2: supporting prediction and staging of thyroid cancer. World J Surg; 2006 Mar;30(3):309-20
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Epidemiologically, thyroid gland tumors are lesions of the highest importance among endocrine tumors in humans.
  • [MeSH-major] Adenocarcinoma, Follicular / pathology. Carcinoma, Papillary / pathology. Neoplasm Staging / methods. Thyroid Neoplasms / pathology

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16479347.001).
  • [ISSN] 0364-2313
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


37. Choi YJ, Yun JS, Kim DH: Clinical and ultrasound features of cytology diagnosed follicular neoplasm. Endocr J; 2009;56(3):383-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma, Follicular / ultrasonography. Thyroid Neoplasms / ultrasonography
  • [MeSH-minor] Adenoma, Oxyphilic / pathology. Adult. Aged. Female. Humans. Male. Middle Aged. Thyroid Gland / pathology. Thyroid Gland / ultrasonography. Ultrasonography, Doppler, Color

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19164864.001).
  • [ISSN] 1348-4540
  • [Journal-full-title] Endocrine journal
  • [ISO-abbreviation] Endocr. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


38. Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, Moon Y, Ram S, Zimmerman S, Lee JH, Pisters PW, Tamm EP, Fleming JB, Abbruzzese JL, Evans DB: Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol; 2008 May;15(5):1356-66
SciCrunch. SciCrunch Registry: Resource: Registry .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The most common histologies of pancreatic tumors were pancreatic ductal adenocarcinoma (55.3%) and neuroendocrine carcinoma (16.3%).

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18256882.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P20 CA101936; United States / NCI NIH HHS / CA / CA101936-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


39. Weyemi U, Caillou B, Talbot M, Ameziane-El-Hassani R, Lacroix L, Lagent-Chevallier O, Al Ghuzlan A, Roos D, Bidart JM, Virion A, Schlumberger M, Dupuy C: Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues. Endocr Relat Cancer; 2010 Mar;17(1):27-37
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To date, in the thyroid gland, only DUOX1/2 NOX systems have been described.
  • [MeSH-major] Adenocarcinoma, Follicular / enzymology. Adenoma / enzymology. Carcinoma / enzymology. Carcinoma, Papillary / enzymology. NADPH Oxidase / biosynthesis. Neoplasm Proteins / biosynthesis. Reactive Oxygen Species / metabolism. Thyroid Gland / enzymology. Thyroid Neoplasms / enzymology

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • Hazardous Substances Data Bank. HYDROGEN PEROXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19779036.001).
  • [ISSN] 1479-6821
  • [Journal-full-title] Endocrine-related cancer
  • [ISO-abbreviation] Endocr. Relat. Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / RNA, Small Interfering; 0 / Reactive Oxygen Species; 9002-71-5 / Thyrotropin; BBX060AN9V / Hydrogen Peroxide; EC 1.6.3.- / NOX4 protein, human; EC 1.6.3.1 / CYBA protein, human; EC 1.6.3.1 / DUOX1 protein, human; EC 1.6.3.1 / NADPH Oxidase
  •  go-up   go-down


40. Kocjan G: Fine needle aspiration cytology of the pancreas: a guide to the diagnostic approach. Coll Antropol; 2010 Jun;34(2):749-56
MedlinePlus Health Information. consumer health - Pancreatic Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Despite the advances in the imaging techniques, management options for patients are limited and a malignant diagnosis of solid lesions still carries a high mortality rate.
  • The importance of a cytopathologist in preoperative diagnosis, as a member of the multidisciplinary team, is exemplified in the management of patients with neoplastic cysts.
  • A cytological diagnosis can be obtained with minimally invasive techniques that utilize CT US or EUS.
  • [MeSH-minor] Adenocarcinoma / pathology. Cystadenoma / pathology. Endocrine Gland Neoplasms / pathology. Humans. Teratoma / pathology

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20698166.001).
  • [ISSN] 0350-6134
  • [Journal-full-title] Collegium antropologicum
  • [ISO-abbreviation] Coll Antropol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Croatia
  • [Number-of-references] 62
  •  go-up   go-down


41. Badger SA, Brant JL, Jones C, McClements J, Loughrey MB, Taylor MA, Diamond T, McKie LD: The role of surgery for pancreatic cancer: a 12-year review of patient outcome. Ulster Med J; 2010 May;79(2):70-5
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Survival was worse with adenocarcinoma compared to all other pathologies (p=0.013), while periampullary tumours had a better prognosis compared to other locations (p=0.019).
  • [MeSH-major] Adenocarcinoma / surgery. Endocrine Gland Neoplasms / surgery. Pancreatectomy. Pancreatic Neoplasms / surgery

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Cancer. 2006 Aug 21;95(4):445-9 [16880789.001]
  • [Cites] Br J Surg. 2004 Nov;91(11):1410-27 [15499648.001]
  • [Cites] Pancreas. 2006 Oct;33(3):240-5 [17003644.001]
  • [Cites] Tumori. 2006 Sep-Oct;92(5):416-22 [17168435.001]
  • [Cites] Ann Surg. 2007 May;245(5):777-83 [17457171.001]
  • [Cites] Ann Surg. 2007 Jul;246(1):52-60 [17592291.001]
  • [Cites] Eur J Surg Oncol. 2007 Sep;33(7):892-7 [17398060.001]
  • [Cites] Nat Clin Pract Oncol. 2007 Sep;4(9):526-35 [17728711.001]
  • [Cites] Ann Surg. 2008 Jul;248(1):97-103 [18580212.001]
  • [Cites] Annu Rev Med. 2009;60:405-15 [18759554.001]
  • [Cites] J Surg Oncol. 2000 Apr;73(4):212-8 [10797334.001]
  • [Cites] Am J Surg. 2000 Jul;180(1):13-7 [11036132.001]
  • [Cites] Ann Surg. 2001 Dec;234(6):758-68 [11729382.001]
  • [Cites] Eur J Cancer. 2004 Mar;40(4):549-58 [14962722.001]
  • [Cites] Lancet. 2004 Mar 27;363(9414):1049-57 [15051286.001]
  • [Cites] Am Surg. 2004 Mar;70(3):235-40; discussion 240 [15055847.001]
  • [Cites] N Engl J Med. 1979 Dec 20;301(25):1364-9 [503167.001]
  • [Cites] Aust N Z J Surg. 1984 Feb;54(1):53-8 [6586168.001]
  • [Cites] Am J Surg. 1986 Jan;151(1):141-9 [3946745.001]
  • [Cites] Ann Surg. 1986 Oct;204(4):411-8 [3767476.001]
  • [Cites] Gastroenterology. 1994 Jul;107(1):219-30 [8020665.001]
  • [Cites] Cancer. 1995 Apr 15;75(8):2069-76 [7697596.001]
  • [Cites] Ann Surg. 1997 Sep;226(3):248-57; discussion 257-60 [9339931.001]
  • [Cites] Am J Clin Pathol. 1999 Mar;111(3):304-7 [10078104.001]
  • [Cites] Br J Surg. 2006 Oct;93(10):1232-7 [16804874.001]
  • (PMID = 21116422.001).
  • [ISSN] 0041-6193
  • [Journal-full-title] The Ulster medical journal
  • [ISO-abbreviation] Ulster Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Northern Ireland
  • [Other-IDs] NLM/ PMC2993146
  • [Keywords] NOTNLM ; Whipple's procedure / pancreatic cancer / survival
  •  go-up   go-down


42. Musholt PB, Musholt TJ, Morgenstern SC, Worm K, Sheu SY, Schmid KW: Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot. World J Surg; 2008 May;32(5):722-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Furthermore, the findings support the concept that oncocytic neoplasms of the thyroid gland are oncocytic counterparts of the respective histotype (adenoma, FTC, PTC, or poorly differentiated thyroid carcinoma) rather than a separate tumor entity.
  • [MeSH-major] Adenocarcinoma, Follicular / genetics. Adenoma, Oxyphilic / genetics. Carcinoma, Papillary / genetics. Mutation. Proto-Oncogene Proteins B-raf / genetics. Thyroid Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18235983.001).
  • [ISSN] 0364-2313
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.11.1 / BRAF protein, human; EC 2.7.11.1 / Proto-Oncogene Proteins B-raf
  •  go-up   go-down


43. Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Dei Tos AP, Orlandi F, Papotti M: Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer; 2005 Jun;12(2):305-17
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Our data showed that, as compared with the use of single markers, the sequential combination of two markers represents the most accurate immunohistochemical panel in managing patients with a fine-needle aspiration biopsy diagnosis of 'follicular neoplasms', especially in otherwise controversial categories such as oncocytic tumours.
  • [MeSH-major] Adenocarcinoma, Follicular / diagnosis. Biomarkers, Tumor / analysis. Immunohistochemistry. Thyroid Gland / pathology. Thyroid Neoplasms / diagnosis
  • [MeSH-minor] Biopsy, Fine-Needle. Diagnosis, Differential. Humans

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15947105.001).
  • [ISSN] 1351-0088
  • [Journal-full-title] Endocrine-related cancer
  • [ISO-abbreviation] Endocr. Relat. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


44. Calzolari F, Sartori PV, Talarico C, Parmeggiani D, Beretta E, Pezzullo L, Bovo G, Sperlongano P, Monacelli M, Lucchini R, Misso C, Gurrado A, D'Ajello M, Uggeri F, Puxeddu E, Nasi P, Testini M, Rosato L, Barbarisio A, Avenia N: Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study. Anticancer Res; 2008 Sep-Oct;28(5B):2885-8
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study was to detect which neoplasms metastasize most often to the thyroid gland, their clinical features and treatment options.
  • A long delay between the primary tumor and the recurrence warrants surgery and total thyroidectomy seems to be the treatment of choice because of the multifocality of metastasis to the thyroid gland.
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / secondary. Adenocarcinoma / surgery. Adult. Aged. Biopsy, Fine-Needle. Breast Neoplasms / pathology. Carcinoma, Renal Cell / pathology. Carcinoma, Renal Cell / secondary. Carcinoma, Renal Cell / surgery. Colonic Neoplasms / pathology. Female. Follow-Up Studies. Humans. Kidney Neoplasms / pathology. Lung Neoplasms / pathology. Male. Middle Aged. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19031929.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] Greece
  •  go-up   go-down


45. Coyne C, Nikiforov YE: RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii. Endocr Pathol; 2010 Jun;21(2):144-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Malignant transformation of struma ovarii is rare and poorly understood, although this process is thought to be similar to carcinogenesis in malignant tumors of differentiated thyroid tissue originating in the thyroid gland.
  • Genetic alterations in the mitogen-activated protein kinase pathway, including mutations of BRAF, RAS, and RET genes, have been implicated in the development of differentiated thyroid carcinoma arising in the thyroid gland.
  • It provides evidence that tumors developing in this setting involve molecular mechanisms similar to those implicated in tumors developing in the thyroid gland.
  • [MeSH-major] Adenocarcinoma, Papillary / genetics. Neoplasms, Multiple Primary / genetics. Ovarian Neoplasms / genetics. Struma Ovarii / genetics. Thyroid Neoplasms / genetics. ras Proteins / genetics

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19898969.001).
  • [ISSN] 1559-0097
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.10.1 / Proto-Oncogene Proteins c-ret; EC 2.7.10.1 / RET protein, human; EC 2.7.11.1 / BRAF protein, human; EC 2.7.11.1 / Proto-Oncogene Proteins B-raf; EC 3.6.5.2 / ras Proteins
  •  go-up   go-down


46. Sebag F, Calzolari F, Harding J, Sierra M, Palazzo FF, Henry JF: Isolated adrenal metastasis: the role of laparoscopic surgery. World J Surg; 2006 May;30(5):888-92
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary tumours included lung cancer (n = 9), melanoma (n = 3), mesothelioma (n = 1), rhabdomyosarcoma (n = 1), colonic adenocarcinoma (n = 1) and renal cell carcinoma (n = 1).
  • Pathology confirmed the diagnosis of AM.
  • [MeSH-major] Adrenal Gland Neoplasms / secondary. Adrenal Gland Neoplasms / surgery. Adrenalectomy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16547618.001).
  • [ISSN] 0364-2313
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


47. Mhanna T, Ranchere-Vince D, Hervieu V, Tardieu D, Scoazec JY, Partensky C: Clear cell myomelanocytic tumor (PEComa) of the duodenum in a child with a history of neuroblastoma. Arch Pathol Lab Med; 2005 Nov;129(11):1484-6
MedlinePlus Health Information. consumer health - Neuroblastoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The diagnosis was obtained by examination of a biopsy specimen taken during laparoscopy.
  • Examination of the surgical specimen confirmed the diagnosis of PEComa.
  • [MeSH-minor] Adenocarcinoma / diagnosis. Biomarkers, Tumor / analysis. Child. Diagnosis, Differential. Endocrine Gland Neoplasms / diagnosis. Humans. Male. Neoplasms, Second Primary. Pancreaticoduodenectomy. Sarcoma, Clear Cell / diagnosis. Treatment Outcome

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16253032.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


48. Fröhlich E, Machicao F, Wahl R: Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture. Endocr Relat Cancer; 2005 Jun;12(2):291-303
Hazardous Substances Data Bank. THYROGLOBULIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma, Follicular / metabolism. Apoptosis. Radiation-Sensitizing Agents / pharmacology. Thiazolidinediones / pharmacology. Thyroid Gland / drug effects. Thyroid Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • Hazardous Substances Data Bank. PIOGLITAZONE .
  • Hazardous Substances Data Bank. ROSIGLITAZONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Endocr Relat Cancer. 2005 Sep;12(3):681
  • (PMID = 15947104.001).
  • [ISSN] 1351-0088
  • [Journal-full-title] Endocrine-related cancer
  • [ISO-abbreviation] Endocr. Relat. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Annexin A5; 0 / Chromans; 0 / PPAR gamma; 0 / RNA, Messenger; 0 / Radiation-Sensitizing Agents; 0 / Retinoid X Receptor alpha; 0 / Symporters; 0 / Thiazolidinediones; 0 / sodium-iodide symporter; 05V02F2KDG / rosiglitazone; 9010-34-8 / Thyroglobulin; I66ZZ0ZN0E / troglitazone; X4OV71U42S / pioglitazone
  •  go-up   go-down


49. Adolfsson J, Garmo H, Varenhorst E, Ahlgren G, Ahlstrand C, Andrén O, Bill-Axelson A, Bratt O, Damber JE, Hellström K, Hellström M, Holmberg E, Holmberg L, Hugosson J, Johansson JE, Petterson B, Törnblom M, Widmark A, Stattin P: Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scand J Urol Nephrol; 2007;41(6):456-77
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The incidence of prostate cancer is rising rapidly in Sweden and there is a need to better understand the pattern of diagnosis, tumor characteristics and treatment.
  • MATERIAL AND METHODS: Between 1996 and 2005, all new cases of adenocarcinoma of the prostate gland were intended to be registered in the National Prostate Cancer Register (NPCR).
  • This register contains information on diagnosing unit, date of diagnosis, cause of diagnosis, tumor grade, tumor stage according to the TNM classification in force, serum prostate-specific antigen (PSA) levels at diagnosis and primary treatment given within the first 6 months after diagnosis.
  • During the study period there was a considerable decrease in median age at the time of diagnosis, a stage migration towards smaller tumors, a decrease in median serum PSA values at diagnosis, a decrease in the age-standardized incidence rate of men diagnosed with distant metastases or with a PSA level of > 100 ng/ml at diagnosis and an increase in the proportion of tumors with Gleason score <6.
  • Relatively large geographical differences in the median age at diagnosis and the age-standardized incidence of cases with category T1c tumors were observed.
  • In men with localized tumors and a PSA level of <20 ng/ml at diagnosis, expectant treatment was more commonly used in those aged > or =75 years than in those aged <75 years.
  • Also, the pattern of endocrine treatment varied in different parts of Sweden.
  • The patterns of diagnosis and treatment of prostate cancer vary considerably in different parts of Sweden.
  • The NPCR continues to be an important source for research, epidemiological surveillance of the incidence, diagnosis and treatment of prostate cancer.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / therapy. Prostatic Neoplasms / diagnosis. Prostatic Neoplasms / therapy

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17934985.001).
  • [ISSN] 0036-5599
  • [Journal-full-title] Scandinavian journal of urology and nephrology
  • [ISO-abbreviation] Scand. J. Urol. Nephrol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Sweden
  • [Chemical-registry-number] EC 3.4.21.77 / Prostate-Specific Antigen
  •  go-up   go-down


50. Hutchinson CB, Canlas K, Evans JA, Obando JV, Waugh M: Endoscopic ultrasound-guided fine needle aspiration biopsy of the intrapancreatic accessory spleen: a report of 2 cases. Acta Cytol; 2010 May-Jun;54(3):337-40
MedlinePlus Health Information. consumer health - Pancreatic Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Definitive tissue diagnosis in these 2 cases avoided not only unnecessary surgical intervention but also the need for consideration of a "watch and wait" strategy with further imaging and possible additional biopsy attempts.
  • [MeSH-major] Choristoma / diagnosis. Pancreatic Diseases / diagnosis. Spleen
  • [MeSH-minor] Adenocarcinoma / diagnosis. Antigens, CD / metabolism. Biomarkers / metabolism. Biopsy, Fine-Needle. Diagnosis, Differential. Endocrine Gland Neoplasms / diagnosis. Endosonography. Female. Humans. Male. Middle Aged. Pancreatic Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20518423.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Biomarkers
  •  go-up   go-down


51. Capezzone M, Morabito E, Bellitti P, Giannasio P, de Santis D, Bruno R: Ectopic intrathyroidal nonfunctioning parathyroid cyst. Endocr Pract; 2007 Jan-Feb;13(1):56-8
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Measurement of parathyroid hormone in the FNAB fluid showed a high concentration, suggestive of the diagnosis of PC.
  • Histologic examination confirmed the diagnosis of intrathyroidal PC, and a papillary microcarcinoma (6 mm in diameter) was found in the right lobe of the thyroid.
  • [MeSH-major] Adenocarcinoma, Papillary / complications. Adenocarcinoma, Papillary / ultrasonography. Cysts / pathology. Parathyroid Diseases / complications. Thyroid Gland / pathology. Thyroid Neoplasms / complications. Thyroid Neoplasms / ultrasonography. Thyroid Nodule / complications. Thyroid Nodule / ultrasonography

  • MedlinePlus Health Information. consumer health - Parathyroid Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17360302.001).
  • [ISSN] 1934-2403
  • [Journal-full-title] Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • [ISO-abbreviation] Endocr Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


52. Romanchishen AF, Kuz'michev AS, Bogatikov AA, Morozova EB, Chukhlovin AB, Totolian AA: [Clinical significance of functional variants of matrix metalloproteinase genes in thyroid cancer]. Vestn Khir Im I I Grek; 2009;168(1):57-60
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Under analysis were results of genetic investigations of 105 patients with thyroid cancer (TC) treated from 2004 through 2007 in the St. Petersburg City Center of surgery and oncology of the endocrine system organs.
  • It was shown that MMP genes could be a substantial factor of slowing down the rate of malignant growth and invasive properties of cancer of the thyroid gland.
  • [MeSH-major] Adenocarcinoma, Papillary / enzymology. DNA, Neoplasm / genetics. Gene Expression Regulation, Neoplastic. Genetic Variation. Matrix Metalloproteinase 1 / genetics. Matrix Metalloproteinase 3 / genetics. Thyroid Neoplasms / enzymology

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19432148.001).
  • [ISSN] 0042-4625
  • [Journal-full-title] Vestnik khirurgii imeni I. I. Grekova
  • [ISO-abbreviation] Vestn. Khir. Im. I. I. Grek.
  • [Language] rus
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / DNA, Neoplasm; EC 3.4.24.17 / Matrix Metalloproteinase 3; EC 3.4.24.7 / Matrix Metalloproteinase 1
  •  go-up   go-down


53. Lange D, Sporny S, Sygut J, Kulig A, Jarzab M, Kula D, Jarzab B: [Histopathological diagnosis of thyroid cancer in a multicenter trial]. Endokrynol Pol; 2006 Jul-Aug;57(4):336-42
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Histopathological diagnosis of thyroid cancer in a multicenter trial].
  • The studies were sent from centres which agreed to participate in the project and than coded in the independent centre--Department of Nuclear Medicine and Endocrine Oncology.
  • The reference diagnosis was made by an agreement between four expert pathologists (D.L., S.S., J.S. and A.K.).
  • Concerning the diagnosis of cancer histotype, the difference between participants diagnosis and the reference one was even higher.
  • The best concordance was achieved in the diagnosis of papillary thyroid cancer, however, on the cost of cancer overdiagnosis by some participants.
  • CONCLUSION: The study documents a high inter-observer variability of thyroid cancer diagnosis and confirms the lesser accuracy of diagnosis of follicular cancer.
  • [MeSH-major] Adenocarcinoma, Follicular / pathology. Adenoma / pathology. Carcinoma, Papillary / pathology. Goiter, Nodular / pathology. Thyroid Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Histological Techniques / methods. Histological Techniques / standards. Humans. Multicenter Studies as Topic / statistics & numerical data. Observer Variation. Thyroid Gland

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17006833.001).
  • [ISSN] 0423-104X
  • [Journal-full-title] Endokrynologia Polska
  • [ISO-abbreviation] Endokrynol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


54. Todaro M, Iovino F, Eterno V, Cammareri P, Gambara G, Espina V, Gulotta G, Dieli F, Giordano S, De Maria R, Stassi G: Tumorigenic and metastatic activity of human thyroid cancer stem cells. Cancer Res; 2010 Nov 1;70(21):8874-85
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thyroid carcinoma is the most common endocrine malignancy and the first cause of death among endocrine cancers.
  • [MeSH-major] Aldehyde Dehydrogenase / metabolism. Cell Transformation, Neoplastic / pathology. Lung Neoplasms / secondary. Neoplastic Stem Cells / pathology. Thyroid Gland / pathology. Thyroid Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma, Follicular / enzymology. Adenocarcinoma, Follicular / pathology. Adult. Aged. Animals. Blotting, Western. Carcinoma / enzymology. Carcinoma / pathology. Carcinoma, Papillary / enzymology. Carcinoma, Papillary / pathology. Case-Control Studies. Cell Adhesion. Cell Movement. Cell Proliferation. Female. Flow Cytometry. Fluorescent Antibody Technique. Humans. Immunoenzyme Techniques. Male. Mice. Mice, Inbred NOD. Mice, Nude. Mice, SCID. Middle Aged. Neoplasm Invasiveness. Proto-Oncogene Proteins c-akt / metabolism. Proto-Oncogene Proteins c-met / metabolism. RNA, Messenger / genetics. Reverse Transcriptase Polymerase Chain Reaction. Tumor Stem Cell Assay. Xenograft Model Antitumor Assays. Young Adult


55. Enomoto K, Sakurai K, Amano S, Shiono M: [A case of malignant lymphoma that seemed to be thyroid cancer lymph nodes recurrence]. Gan To Kagaku Ryoho; 2008 Nov;35(12):2213-5
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A tumor in the survival thyroid gland was confirmed in 1995.
  • In February 2007, the tumor of the survival thyroid gland was enlarged.
  • Histopathology diagnosis showed it to be of a papillary adenocarcinoma of thyroid recurrence.
  • The diagnosis was malignant lymphoma.

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • Genetic Alliance. consumer health - Thyroid Lymphoma.
  • MedlinePlus Health Information. consumer health - Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19106574.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


56. Lo WK, vansonnenberg E, Shankar S, Morrison PR, Silverman SG, Tuncali K, Rabin M: Percutaneous CT-guided radiofrequency ablation of symptomatic bilateral adrenal metastases in a single session. J Vasc Interv Radiol; 2006 Jan;17(1):175-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the present case, a 71-year-old man with a diagnosis of lung cancer and painful bilateral metastases to the adrenal glands underwent percutaneous CT-guided RF thermal ablation of both adrenal masses in a single session (left adrenal mass, 4.7 cm; right adrenal mass, 4.3 cm), without occurrence of blood pressure instability or other acute complications.
  • Measurement of plasma levels of cortisol, adrenocorticotropic hormone (ACTH), and glucose before and after RF ablation revealed transient changes that suggested preservation of endocrine feedback mechanisms.
  • On further follow-up at 6 months, the patient noted a lack of endocrine sequelae and continued pain relief.
  • [MeSH-major] Adenocarcinoma / surgery. Adrenal Gland Neoplasms / surgery. Catheter Ablation

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16415149.001).
  • [ISSN] 1051-0443
  • [Journal-full-title] Journal of vascular and interventional radiology : JVIR
  • [ISO-abbreviation] J Vasc Interv Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


57. de Ostrovich KK, Lambertz I, Colby JK, Tian J, Rundhaug JE, Johnston D, Conti CJ, DiGiovanni J, Fuchs-Young R: Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo. Am J Pathol; 2008 Sep;173(3):824-34
Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To study the role of IGF-1 in mammary tumorigenesis in vivo, we used transgenic mice in which overexpression of IGF-1 is under the control of the bovine keratin 5 (BK5) promoter and is directed to either the myoepithelial or basal cells in a variety of organs, including the mammary gland.

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 2003 May 15;63(10):2425-33 [12750262.001]
  • [Cites] Endocr Relat Cancer. 2001 Sep;8(3):197-209 [11566611.001]
  • [Cites] Mol Endocrinol. 1989 Mar;3(3):509-17 [2747657.001]
  • [Cites] J Biol Chem. 1990 Dec 5;265(34):21172-8 [2174437.001]
  • [Cites] Carcinogenesis. 1990 Dec;11(12):2245-51 [2265476.001]
  • [Cites] Lancet. 1992 Jan 4;339(8784):1-15 [1345950.001]
  • [Cites] Mol Endocrinol. 1993 Jun;7(6):743-52 [7689695.001]
  • [Cites] Mol Endocrinol. 1994 Apr;8(4):510-7 [8052269.001]
  • [Cites] Differentiation. 1994 Nov;58(1):53-64 [7532601.001]
  • [Cites] Science. 1995 Dec 1;270(5241):1491-4 [7491495.001]
  • [Cites] Endocrinology. 1996 Jan;137(1):321-30 [8536631.001]
  • [Cites] Mutat Res. 1995 Dec;333(1-2):29-35 [8538632.001]
  • [Cites] Environ Health Perspect. 1996 Sep;104(9):938-67 [8899375.001]
  • [Cites] J Biol Chem. 1997 Jan 3;272(1):154-61 [8995241.001]
  • [Cites] J Endocrinol. 1997 Jan;152(1):39-47 [9014838.001]
  • [Cites] Carcinogenesis. 1997 Mar;18(3):459-64 [9067542.001]
  • [Cites] Carcinogenesis. 1997 Mar;18(3):553-9 [9067556.001]
  • [Cites] Cancer Res. 1997 Aug 1;57(15):3079-83 [9242428.001]
  • [Cites] J Androl. 1997 Nov-Dec;18(6):602-11 [9432133.001]
  • [Cites] Lancet. 1998 May 9;351(9113):1393-6 [9593409.001]
  • [Cites] Endocrine. 1998 Jun;8(3):251-9 [9741830.001]
  • [Cites] Mol Endocrinol. 1999 May;13(5):787-96 [10319328.001]
  • [Cites] Am J Pathol. 2005 Feb;166(2):575-84 [15681840.001]
  • [Cites] J Biol Chem. 2001 Mar 30;276(13):9817-24 [11139588.001]
  • [Cites] Microsc Res Tech. 2001 Jan 15;52(2):155-62 [11169863.001]
  • [Cites] Mol Pathol. 2001 Oct;54(5):311-6 [11577173.001]
  • [Cites] Oncogene. 2000 Feb 21;19(8):968-88 [10713680.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3455-60 [10737798.001]
  • [Cites] Cancer Res. 2000 Mar 15;60(6):1561-70 [10749124.001]
  • [Cites] J Mammary Gland Biol Neoplasia. 2000 Jan;5(1):7-17 [10791764.001]
  • [Cites] J Mammary Gland Biol Neoplasia. 2000 Jan;5(1):19-30 [10791765.001]
  • [Cites] J Mammary Gland Biol Neoplasia. 2000 Jan;5(1):31-42 [10791766.001]
  • [Cites] J Mammary Gland Biol Neoplasia. 2000 Jan;5(1):95-105 [10791772.001]
  • [Cites] Eur J Cancer. 2000 Jun;36(10):1224-8 [10882860.001]
  • [Cites] Neoplasia. 2002 May-Jun;4(3):204-17 [11988840.001]
  • [Cites] Endocrinology. 2002 Jul;143(7):2673-9 [12072401.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):705-12 [12163322.001]
  • [Cites] Breast Cancer Res Treat. 2002 Jun;74(3):199-211 [12206512.001]
  • [Cites] Tumour Biol. 2002 May-Jun;23(3):130-8 [12218293.001]
  • [Cites] J Biol Chem. 2002 Dec 6;277(49):47645-52 [12364325.001]
  • [Cites] Breast Cancer Res. 2002;4(6):231-9 [12473169.001]
  • [Cites] Cancer Res. 2005 May 1;65(9):3781-7 [15867374.001]
  • [Cites] Mol Carcinog. 2005 Oct;44(2):137-45 [16086373.001]
  • [Cites] Endocr Relat Cancer. 2006 Jun;13(2):273-8 [16728563.001]
  • [Cites] Endocr Relat Cancer. 2006 Jun;13(2):583-92 [16728584.001]
  • [Cites] Carcinogenesis. 2007 Mar;28(3):584-94 [17050554.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):763-8 [17416768.001]
  • [Cites] Pituitary. 2007;10(2):129-33 [17487588.001]
  • [Cites] Nat Rev Cancer. 2007 Sep;7(9):659-72 [17721431.001]
  • [Cites] Cancer Res. 2007 Nov 15;67(22):10879-88 [18006833.001]
  • [Cites] Exp Cell Res. 2002 Feb 1;273(1):107-17 [11795951.001]
  • [Cites] Oncology. 1999 Nov;57(4):330-40 [10575321.001]
  • [Cites] Mol Carcinog. 2000 Jan;27(1):10-7 [10642432.001]
  • [Cites] Oncogene. 2000 Feb 17;19(7):889-98 [10702797.001]
  • [Cites] J Biol Chem. 2000 Jul 14;275(28):21695-702 [10777488.001]
  • [Cites] J Natl Cancer Inst. 2000 Sep 20;92(18):1472-89 [10995803.001]
  • [Cites] J Biol Chem. 2000 Nov 17;275(46):35893-901 [10967123.001]
  • [Cites] J Endocrinol. 2000 Aug;166(2):329-38 [10927622.001]
  • [Cites] J Nutr. 1979 May;109(5):925-6 [438904.001]
  • (PMID = 18688034.001).
  • [ISSN] 1525-2191
  • [Journal-full-title] The American journal of pathology
  • [ISO-abbreviation] Am. J. Pathol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P30 CA016672; United States / NCI NIH HHS / CA / R01 CA037111; United States / NCI NIH HHS / CA / CA16672; United States / NCI NIH HHS / CA / CA 104114; United States / NCI NIH HHS / CA / R01 CA104114; United States / NIEHS NIH HHS / ES / P30 ES007784; United States / NCI NIH HHS / CA / CA37111; United States / NIEHS NIH HHS / ES / ES07784
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Keratin-5; 0 / Keratin-8; 0 / Receptors, Estrogen; 0 / Receptors, Progesterone; 136601-57-5 / Cyclin D1; 67763-96-6 / Insulin-Like Growth Factor I
  • [Other-IDs] NLM/ PMC2527085
  •  go-up   go-down


58. Chatelain D, Mokrani N, Fléjou JF: [Anal and anal margin tumors]. Ann Pathol; 2007 Dec;27(6):459-75
MedlinePlus Health Information. consumer health - Anal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adenocarcinoma / pathology. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / pathology. Endocrine Gland Neoplasms / epidemiology. Endocrine Gland Neoplasms / pathology. France / epidemiology. Humans. Incidence. Leiomyosarcoma / pathology. Lymphoma / pathology. Melanoma / epidemiology. Melanoma / pathology. Papilloma / pathology. Sarcoma, Kaposi / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18554556.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 110
  •  go-up   go-down


59. Balcerzak W, Bednarz W, Domosławski P, Olewiński R, Kolesińska J, Kaminski Z, Dziarkowska K, Wieczorek P: [Preliminary approach towards construction of peptide libraries as potential tools for diagnosis of malignant thyroid tumors]. Endokrynol Pol; 2006 Jul-Aug;57(4):307-13
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Preliminary approach towards construction of peptide libraries as potential tools for diagnosis of malignant thyroid tumors].
  • INTRODUCTION: Cancer of thyroid gland is the most common malignancy of the endocrine system.
  • The treatment improvement could be achieved by early diagnosis.
  • [MeSH-major] Adenocarcinoma, Follicular / pathology. Adenoma, Oxyphilic / pathology. Biomarkers, Tumor / analysis. Carcinoma, Papillary, Follicular / pathology. Peptide Library. Thyroid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17006829.001).
  • [ISSN] 0423-104X
  • [Journal-full-title] Endokrynologia Polska
  • [ISO-abbreviation] Endokrynol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Galectin 3; 0 / Peptide Library; EC 1.11.1.8 / Iodide Peroxidase
  •  go-up   go-down


60. Lee S, Hong SW, Moon WC, Oh MR, Lee JK, Ahn CW, Cha BS, Kim KR, Lee HC, Lim SK: High prevalence of c-RET expression in papillary thyroid carcinomas from the Korean population. Thyroid; 2005 Mar;15(3):259-66
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Second, germ-line point mutations are responsible for the development of medullary thyroid carcinomas and multiple endocrine neoplasia type 2 (MEN 2).
  • [MeSH-major] Adenocarcinoma, Papillary / genetics. Thyroid Neoplasms / genetics
  • [MeSH-minor] Asian Continental Ancestry Group / genetics. DNA Primers. Humans. Immunohistochemistry. Korea. Prevalence. Reverse Transcriptase Polymerase Chain Reaction. Thyroid Gland / pathology

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15785245.001).
  • [ISSN] 1050-7256
  • [Journal-full-title] Thyroid : official journal of the American Thyroid Association
  • [ISO-abbreviation] Thyroid
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA Primers
  •  go-up   go-down


61. Ferru A, Fromont G, Gibelin H, Guilhot J, Savagner F, Tourani JM, Kraimps JL, Larsen CJ, Karayan-Tapon L: The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression. Br J Cancer; 2006 Dec 18;95(12):1670-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma, Follicular / genetics. Adenocarcinoma, Follicular / metabolism. Adenocarcinoma, Follicular / pathology. Adult. Aged. Aged, 80 and over. Carcinoma, Papillary / genetics. Carcinoma, Papillary / metabolism. Carcinoma, Papillary / pathology. Cell Differentiation. Disease Progression. Humans. Immunoenzyme Techniques. Middle Aged. RNA, Messenger / genetics. RNA, Messenger / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Thyroid Gland / metabolism. Thyroid Gland / pathology

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 1998 Sep 1;58(17):3926-31 [9731504.001]
  • [Cites] Nature. 1997 May 15;387(6630):299-303 [9153396.001]
  • [Cites] Genes Chromosomes Cancer. 1997 Jun;19(2):112-23 [9172002.001]
  • [Cites] Genes Dev. 1997 Jun 1;11(11):1479-92 [9192874.001]
  • [Cites] Nature. 1998 Sep 10;395(6698):124-5 [9744267.001]
  • [Cites] Nature. 1998 Sep 10;395(6698):125-6 [9744268.001]
  • [Cites] Genes Dev. 1998 Oct 1;12(19):2984-91 [9765200.001]
  • [Cites] Horm Metab Res. 1998 Sep;30(9):549-54 [9808321.001]
  • [Cites] Biochim Biophys Acta. 1998 Oct 14;1378(2):F115-77 [9823374.001]
  • [Cites] Pol J Pathol. 2004;55(4):143-8 [15757201.001]
  • [Cites] Endocr Relat Cancer. 2005 Jun;12(2):245-62 [15947100.001]
  • [Cites] Histopathology. 2005 Sep;47(3):281-91 [16115229.001]
  • [Cites] Int J Cancer. 1997 Feb 20;74(1):57-63 [9036870.001]
  • [Cites] Genes Chromosomes Cancer. 2000 Mar;27(3):244-51 [10679913.001]
  • [Cites] Nat Cell Biol. 2000 Mar;2(3):148-55 [10707085.001]
  • [Cites] Clin Cancer Res. 2000 May;6(5):1819-25 [10815903.001]
  • [Cites] Diagn Cytopathol. 2000 Aug;23(2):77-81 [10888749.001]
  • [Cites] Clin Cancer Res. 2000 Jul;6(7):2777-87 [10914724.001]
  • [Cites] Science. 2000 Aug 25;289(5483):1357-60 [10958784.001]
  • [Cites] Genes Dev. 2000 Sep 15;14(18):2358-65 [10995391.001]
  • [Cites] Mod Pathol. 2000 Sep;13(9):1014-9 [11007042.001]
  • [Cites] Ann Oncol. 2000 Sep;11(9):1083-9 [11061600.001]
  • [Cites] Cancer Lett. 2001 Feb 26;163(2):143-56 [11165748.001]
  • [Cites] Clin Cancer Res. 2001 Mar;7(3):544-50 [11297246.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7025-8 [11416182.001]
  • [Cites] Nat Rev Mol Cell Biol. 2001 Oct;2(10):731-7 [11584300.001]
  • [Cites] Blood. 2002 Feb 15;99(4):1411-8 [11830494.001]
  • [Cites] Lancet Oncol. 2002 Jul;3(7):407-14 [12142170.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10611-6 [12149460.001]
  • [Cites] J Pathol. 2002 Oct;198(2):157-62 [12237874.001]
  • [Cites] Mod Pathol. 2002 Oct;15(10):1106; author reply 1106-7 [12379759.001]
  • [Cites] Oncogene. 2003 Mar 27;22(12):1822-35 [12660818.001]
  • [Cites] Clin Lab Haematol. 2003 Aug;25(4):233-7 [12890162.001]
  • [Cites] Pathol Res Pract. 2003;199(6):399-404 [12924440.001]
  • [Cites] J Hum Genet. 2004;49(6):312-8 [15118916.001]
  • [Cites] Surgery. 1987 Dec;102(6):1088-95 [3686348.001]
  • [Cites] Oncogene. 1990 Apr;5(4):565-70 [2183158.001]
  • [Cites] J Clin Invest. 1993 Jan;91(1):179-84 [8423216.001]
  • [Cites] Nature. 1993 Dec 16;366(6456):704-7 [8259215.001]
  • [Cites] Oncogene. 1996 Apr 18;12(8):1821-6 [8622903.001]
  • [Cites] Int J Cancer. 1996 Jul 3;67(1):29-34 [8690521.001]
  • [Cites] Genes Chromosomes Cancer. 1996 May;16(1):1-14 [9162191.001]
  • [Cites] Diagn Mol Pathol. 1996 Mar;5(1):45-52 [8919545.001]
  • [Cites] Oncogene. 1997 Nov 13;15(20):2475-81 [9395243.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Feb;83(2):525-30 [9467569.001]
  • [Cites] Endocrine. 1998 Feb;8(1):61-4 [9666346.001]
  • [Cites] Oncogene. 1998 Jun 4;16(22):2865-78 [9671407.001]
  • [Cites] Mol Cell Biol. 1998 Sep;18(9):5284-90 [9710613.001]
  • (PMID = 17117177.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cyclin-Dependent Kinase Inhibitor p16; 0 / RNA, Messenger; 0 / Tumor Suppressor Protein p14ARF
  • [Other-IDs] NLM/ PMC2360765
  •  go-up   go-down


62. Kimura N, Kimura I: Podoplanin as a marker for mesothelioma. Pathol Int; 2005 Feb;55(2):83-6
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The utility of podoplanin for the histological diagnosis of tumors was then investigated, especially for mesothelioma.
  • Immunohistochemical study of podoplanin was carried out in five malignant mesotheliomas and 118 other tumors including 93 adenocarcinomas, four squamous cell carcinomas, six gastrointestinal stromal tumors and five endocrine tumors.
  • Among the many antibodies used for differential diagnosis of malignant mesothelioma, podoplanin has the potential to be an excellent tumor marker in both specificity and sensitivity.
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adrenal Gland Neoplasms / diagnosis. Carcinoid Tumor / diagnosis. Carcinoma, Squamous Cell / diagnosis. Diagnosis, Differential. Female. Gastrointestinal Stromal Tumors / diagnosis. Humans. Pheochromocytoma / diagnosis

  • MedlinePlus Health Information. consumer health - Mesothelioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15693854.001).
  • [ISSN] 1320-5463
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Membrane Glycoproteins; 0 / PDPN protein, human
  •  go-up   go-down


63. Seigne C, Fontanière S, Carreira C, Lu J, Tong WM, Fontanière B, Wang ZQ, Zhang CX, Frappart L: Characterisation of prostate cancer lesions in heterozygous Men1 mutant mice. BMC Cancer; 2010;10:395
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Mutations of the MEN1 gene predispose to multiple endocrine neoplasia type 1 (MEN1) syndrome.
  • CONCLUSION: Our work suggests the possible involvement of Men1 inactivation in the tumorigenesis of the prostate gland.
  • [MeSH-major] Adenocarcinoma / genetics. Adenocarcinoma / pathology. Loss of Heterozygosity. Prostatic Neoplasms / genetics. Prostatic Neoplasms / pathology. Proto-Oncogene Proteins / physiology


64. Gil-Puig C, Seoane S, Blanco M, Macia M, Garcia-Caballero T, Segura C, Perez-Fernandez R: Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation. Eur J Endocrinol; 2005 Aug;153(2):335-44
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The transcription factor pituitary-1 (Pit-1) is mainly expressed in the pituitary gland, where it has critical roles in cell differentiation and as a transcriptional factor for GH and prolactin (PRL).
  • It is also expressed in human extrapituitary tissues (placenta, lymphoid and haematopoietic tissues) and cell lines (human breast adenocarcinoma cells, MCF-7).
  • Despite the widely suggested roles of GH and PRL in the progression of proliferative mammary disorders, Pit-1 expression in human mammary gland has not yet been reported.

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16061841.001).
  • [ISSN] 0804-4643
  • [Journal-full-title] European journal of endocrinology
  • [ISO-abbreviation] Eur. J. Endocrinol.
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / POU1F1 protein, human; 0 / RNA, Messenger; 0 / Transcription Factor Pit-1; 0 / Transcription Factors; 12629-01-5 / Human Growth Hormone; 67763-96-6 / Insulin-Like Growth Factor I
  •  go-up   go-down


65. Mathonnet M: [Lymph node dissection in non-medullary differentiated thyroid carcinoma]. Ann Chir; 2006 Jul-Aug;131(6-7):361-8
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Papillary and follicular thyroid carcinomas are the most common form of endocrine carcinomas.
  • [MeSH-major] Adenocarcinoma, Follicular / surgery. Carcinoma, Papillary / surgery. Lymph Node Excision. Thyroid Neoplasms / surgery
  • [MeSH-minor] Adult. Age Factors. Biopsy, Needle. Data Interpretation, Statistical. Female. Humans. Lymph Nodes / pathology. Lymphatic Metastasis / diagnosis. Lymphatic Metastasis / pathology. Male. Middle Aged. Multivariate Analysis. Neck Dissection. Neoplasm Metastasis. Neoplasm Recurrence, Local. Neoplasm Staging. Prognosis. Retrospective Studies. Risk Factors. Sensitivity and Specificity. Sentinel Lymph Node Biopsy. Thyroid Gland / pathology. Thyroidectomy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16329987.001).
  • [ISSN] 0003-3944
  • [Journal-full-title] Annales de chirurgie
  • [ISO-abbreviation] Ann Chir
  • [Language] fre
  • [Publication-type] Comparative Study; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 52
  •  go-up   go-down


66. McLaughlin PJ, Zagon IS, Park SS, Conway A, Donahue RN, Goldenberg D: Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis. BMC Cancer; 2009;9:369
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Carcinoma of the thyroid gland is an uncommon cancer, but the most frequent malignancy of the endocrine system.
  • [MeSH-major] Adenocarcinoma, Follicular / metabolism. Cell Proliferation. Enkephalin, Methionine / metabolism. Receptors, Opioid / metabolism. Thyroid Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Urol. 1999 Dec;162(6):2186-91 [10569617.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Aug;85(8):2889-96 [10946899.001]
  • [Cites] Int J Oncol. 2000 Nov;17(5):1053-61 [11029512.001]
  • [Cites] Rev Endocr Metab Disord. 2000 Apr;1(3):183-96 [11708296.001]
  • [Cites] Brain Res Brain Res Rev. 2002 Feb;38(3):351-76 [11890982.001]
  • [Cites] Cancer. 2003 Apr 1;97(7):1701-10 [12655527.001]
  • [Cites] Neuropeptides. 2003 Apr;37(2):79-88 [12747939.001]
  • [Cites] Int J Oncol. 2004 Jan;24(1):227-32 [14654962.001]
  • [Cites] Brain Res. 1993 Dec 10;630(1-2):295-302 [8118696.001]
  • [Cites] Head Neck. 1995 Jan-Feb;17(1):41-7; discussion 47-8 [7883548.001]
  • [Cites] Brain Res. 1995 Feb 6;671(1):105-11 [7728521.001]
  • [Cites] Am J Physiol. 1996 Sep;271(3 Pt 2):R511-8 [8853370.001]
  • [Cites] J Clin Endocrinol Metab. 1997 Jun;82(6):1857-62 [9177396.001]
  • [Cites] Semin Surg Oncol. 1999 Jan-Feb;16(1):64-9 [9890741.001]
  • [Cites] Clin Cancer Res. 2008 Jan 15;14(2):589-96 [18223235.001]
  • [Cites] Mol Cancer. 2008;7:5 [18190706.001]
  • [Cites] CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 [18287387.001]
  • [Cites] Int J Oncol. 2008 Aug;33(2):317-23 [18636152.001]
  • [Cites] Exp Biol Med (Maywood). 2008 Aug;233(8):968-79 [18480416.001]
  • [Cites] Int J Oncol. 2008 Oct;33(4):751-7 [18813788.001]
  • [Cites] J Clin Endocrinol Metab. 2008 Nov;93(11):4331-41 [18713817.001]
  • [Cites] Thyroid. 2008 Nov;18(11):1165-70 [19014324.001]
  • [Cites] Am J Physiol Regul Integr Comp Physiol. 2009 Oct;297(4):R1154-61 [19675283.001]
  • [Cites] Int J Oncol. 1999 Mar;14(3):577-84 [10024694.001]
  • [Cites] Int J Oncol. 1999 May;14(5):991-8 [10200353.001]
  • [Cites] Anat Rec A Discov Mol Cell Evol Biol. 2005 Jan;282(1):24-37 [15584033.001]
  • [Cites] CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 [15761078.001]
  • [Cites] Am J Otolaryngol. 2005 Jul-Aug;26(4):249-60 [15991091.001]
  • [Cites] Int J Mol Med. 2007 Mar;19(3):421-8 [17273790.001]
  • [Cites] Int J Oncol. 2007 Apr;30(4):775-83 [17332915.001]
  • [Cites] Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4519-27 [17671138.001]
  • [Cites] J Clin Endocrinol Metab. 2007 Aug;92(8):2902-9 [17550961.001]
  • [Cites] Cancer Res. 2007 Nov 1;67(21):10511-8 [17974995.001]
  • [Cites] J Clin Endocrinol Metab. 2007 Dec;92(12):4712-8 [17878251.001]
  • (PMID = 19835629.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Receptors, Opioid; 0 / methionine-enkephalin receptor; 58569-55-4 / Enkephalin, Methionine
  • [Other-IDs] NLM/ PMC2770570
  •  go-up   go-down


67. Maldonado-Pérez D, Brown P, Morgan K, Millar RP, Thompson EA, Jabbour HN: Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway. Biochim Biophys Acta; 2009 Jul;1793(7):1315-24
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / metabolism. Calcineurin / metabolism. Endometrial Neoplasms / metabolism. Interleukin-8 / metabolism. NFATC Transcription Factors / metabolism. Vascular Endothelial Growth Factor, Endocrine-Gland-Derived / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Science. 1992 Dec 11;258(5089):1798-801 [1281554.001]
  • [Cites] Nature. 2001 Aug 30;412(6850):877-84 [11528470.001]
  • [Cites] Mol Cell Endocrinol. 1993 Aug;94(2):195-204 [8224523.001]
  • [Cites] J Biol Chem. 1994 Mar 18;269(11):8582-9 [7510691.001]
  • [Cites] Annu Rev Immunol. 1997;15:707-47 [9143705.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 May 13;94(10):4919-24 [9144165.001]
  • [Cites] J Clin Endocrinol Metab. 1998 May;83(5):1783-7 [9589693.001]
  • [Cites] Mol Pharmacol. 1998 Aug;54(2):264-72 [9687567.001]
  • [Cites] Hum Reprod. 1998 Aug;13(8):2292-5 [9756313.001]
  • [Cites] J Biol Chem. 2004 Nov 26;279(48):50537-54 [15448146.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16813-8 [15548611.001]
  • [Cites] Science. 2005 Jun 24;308(5730):1923-7 [15976302.001]
  • [Cites] J Leukoc Biol. 2005 Aug;78(2):426-34 [15908459.001]
  • [Cites] Free Radic Biol Med. 2005 Sep 15;39(6):719-27 [16109302.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13075-80 [16131541.001]
  • [Cites] Endocrinology. 2006 Jan;147(1):88-95 [16210375.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4140-5 [16537498.001]
  • [Cites] FEBS J. 2006 May;273(10):2100-9 [16649988.001]
  • [Cites] Neurogastroenterol Motil. 2006 Jun;18(6):455-63 [16700725.001]
  • [Cites] FEBS Lett. 2006 Oct 30;580(25):5965-73 [17046757.001]
  • [Cites] J Biol Chem. 2002 Mar 8;277(10):8724-9 [11751915.001]
  • [Cites] J Biol Chem. 2002 May 31;277(22):19276-80 [11886876.001]
  • [Cites] Am J Reprod Immunol. 2002 Apr;47(4):213-21 [12069388.001]
  • [Cites] Biochim Biophys Acta. 2002 Dec 12;1579(2-3):173-9 [12427552.001]
  • [Cites] Hum Cell. 2002 Sep;15(3):104-17 [12703541.001]
  • [Cites] Nat Struct Biol. 2003 Oct;10(10):807-11 [12949491.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2870-5 [14976250.001]
  • [Cites] Cancer Res. 2004 Mar 15;64(6):1906-10 [15026321.001]
  • [Cites] J Clin Endocrinol Metab. 2004 May;89(5):2463-9 [15126578.001]
  • [Cites] Mol Endocrinol. 2004 Jun;18(6):1533-45 [15044590.001]
  • [Cites] Blood. 2004 Jul 1;104(1):149-58 [15016650.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Aug;89(8):4078-88 [15292351.001]
  • [Cites] J Vasc Res. 2004 Jul-Aug;41(4):334-44 [15263820.001]
  • [Cites] Science. 1989 Mar 17;243(4897):1464-6 [2648569.001]
  • [Cites] Mol Cancer Res. 2006 Nov;4(11):811-20 [17114339.001]
  • [Cites] Trends Endocrinol Metab. 2007 Mar;18(2):66-72 [17208447.001]
  • [Cites] J Biol Chem. 2007 Jul 6;282(27):19666-75 [17491020.001]
  • [Cites] Am J Reprod Immunol. 2007 Aug;58(2):129-37 [17631006.001]
  • [Cites] J Biol Chem. 2007 Aug 10;282(32):23387-401 [17565986.001]
  • [Cites] FASEB J. 2007 Sep;21(11):2980-93 [17442730.001]
  • [Cites] FASEB J. 2007 Oct;21(12):3023-8 [17595344.001]
  • [Cites] Endocrinology. 2008 Jun;149(6):2877-87 [18339712.001]
  • [Cites] Endocrinology. 2008 Jul;149(7):3470-7 [18372330.001]
  • [Cites] Eur Cytokine Netw. 2008 Dec;19(4):166-75 [19103522.001]
  • [Cites] J Immunol. 2000 Jun 1;164(11):5944-51 [10820277.001]
  • [Cites] Circ Res. 2000 Dec 8;87(12):E61-8 [11110780.001]
  • [Cites] Mol Pharmacol. 2001 Apr;59(4):692-8 [11259612.001]
  • [Cites] Oncogene. 2001 Apr 30;20(19):2476-89 [11402342.001]
  • [Cites] Mol Cell Biol. 1993 Oct;13(10):6137-46 [8413215.001]
  • (PMID = 19348862.001).
  • [ISSN] 0006-3002
  • [Journal-full-title] Biochimica et biophysica acta
  • [ISO-abbreviation] Biochim. Biophys. Acta
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / MRC/ MC/ U127681325; United Kingdom / Medical Research Council / / MRC/ MC/ U127684438; United Kingdom / Medical Research Council / / MRC/ U.1276.00.004.00002.01/2(61014)
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Interleukin-8; 0 / Intracellular Signaling Peptides and Proteins; 0 / Muscle Proteins; 0 / NFATC Transcription Factors; 0 / RCAN1 protein, human; 0 / RNA, Small Interfering; 0 / Transcription Factor AP-1; 0 / Vascular Endothelial Growth Factor, Endocrine-Gland-Derived; EC 3.1.3.16 / Calcineurin
  • [Other-IDs] NLM/ PMC2707763; NLM/ UKMS5150
  •  go-up   go-down


68. Prins GS, Birch L, Tang WY, Ho SM: Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol; 2007 Apr-May;23(3):374-82
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Using the neonatal rodent as an animal model, it has been shown that early exposure to high doses of estradiol results in an increased incidence of prostatic lesions with aging which include hyperplasia, inflammatory cell infiltration and prostatic intraepithelial neoplasia or PIN, believed to be the precursor lesion for prostatic adenocarcinoma.
  • Furthermore, recent studies performed with low-dose estradiol exposures during development as well as exposures to environmentally relevant doses of the endocrine disruptor bisphenol A show increased susceptibility to PIN lesions with aging following additional adult exposure to estradiol.
  • Gene methylation analysis revealed a potential epigenetic basis for the estrogen imprinting of the prostate gland.
  • Taken together, our results suggest that a full range of estrogenic exposures during the postnatal critical period - from environmentally relevant bisphenol A exposure to low-dose and pharmacologic estradiol exposures - results in an increased incidence and susceptibility to neoplastic transformation of the prostate gland in the aging male which may provide a fetal basis for this adult disease.

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • MedlinePlus Health Information. consumer health - Reproductive Hazards.
  • MedlinePlus Health Information. consumer health - Seniors' Health.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Endocrinology. 1995 Mar;136(3):1303-14 [7867585.001]
  • [Cites] Proc Soc Exp Biol Med. 1995 Jan;208(1):116-9 [7534422.001]
  • [Cites] Ann Intern Med. 1995 May 15;122(10):778-88 [7717601.001]
  • [Cites] Carcinogenesis. 1995 Jun;16(6):1311-7 [7788848.001]
  • [Cites] Acta Anat (Basel). 1995;153(1):1-11 [8560954.001]
  • [Cites] BMJ. 1996 Aug 10;313(7053):337-41 [8760741.001]
  • [Cites] J Biol Chem. 1996 Dec 13;271(50):31779-82 [8943214.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):2056-61 [9050904.001]
  • [Cites] Endocrinology. 1997 May;138(5):1801-9 [9112371.001]
  • [Cites] Br J Urol. 1997 Apr;79 Suppl 2:18-26 [9126066.001]
  • [Cites] Dev Dyn. 1997 May;209(1):127-38 [9142502.001]
  • [Cites] Cancer Res. 1997 Oct 1;57(19):4356-9 [9331098.001]
  • [Cites] Endocrinology. 1998 Mar;139(3):874-83 [9492016.001]
  • [Cites] Endocrinology. 1999 Jan;140(1):405-15 [9886852.001]
  • [Cites] Cell. 1999 Jan 22;96(2):225-33 [9988217.001]
  • [Cites] Endocrinology. 1999 Jun;140(6):2801-13 [10342871.001]
  • [Cites] Natl Cancer Inst Monogr. 1963 Oct;12:1-27 [14072991.001]
  • [Cites] J Steroid Biochem Mol Biol. 2004 Nov;92(4):237-53 [15663987.001]
  • [Cites] Dev Biol. 2005 Feb 15;278(2):396-414 [15680359.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 May 10;102(19):7014-9 [15867144.001]
  • [Cites] Cancer Res. 2001 Aug 15;61(16):6089-97 [11507058.001]
  • [Cites] Clin Cancer Res. 2001 Oct;7(10):3092-6 [11595700.001]
  • [Cites] Biol Reprod. 2001 Nov;65(5):1496-505 [11673267.001]
  • [Cites] Biol Reprod. 2001 Nov;65(5):1506-17 [11673268.001]
  • [Cites] Reprod Fertil Dev. 2001;13(4):241-52 [11800163.001]
  • [Cites] Cancer Res. 2002 Mar 1;62(5):1370-6 [11888907.001]
  • [Cites] Environ Health Perspect. 2002 Apr;110(4):427-31 [11940462.001]
  • [Cites] Prostate. 2002 Jun 1;52(1):69-81 [11992621.001]
  • [Cites] J Urol. 2002 Jul;168(1):9-12 [12050481.001]
  • [Cites] Endocrinology. 2002 Sep;143(9):3628-40 [12193579.001]
  • [Cites] Toxicol Appl Pharmacol. 2002 Aug 15;183(1):10-22 [12217638.001]
  • [Cites] Cancer Biol Ther. 2002 May-Jun;1(3):268-76 [12432276.001]
  • [Cites] J Biol Chem. 2003 Feb 21;278(8):5493-6 [12493749.001]
  • [Cites] Development. 2003 May;130(10):2061-9 [12668621.001]
  • [Cites] Anticancer Drugs. 2003 Jun;14(5):377-81 [12782945.001]
  • [Cites] Endocrinology. 2003 Nov;144(11):4841-50 [12960060.001]
  • [Cites] Clin Prostate Cancer. 2003 Jun;2(1):24-31 [15046680.001]
  • [Cites] J Androl. 2004 May-Jun;25(3):330-7 [15064308.001]
  • [Cites] Reprod Toxicol. 2004 May;18(3):399-406 [15082075.001]
  • [Cites] Biochem Pharmacol. 2004 Sep 15;68(6):981-8 [15313391.001]
  • [Cites] Dev Biol. 2004 Sep 15;273(2):257-75 [15328011.001]
  • [Cites] J Clin Endocrinol Metab. 1974 Jan;38(1):113-25 [4809636.001]
  • [Cites] Endocr Rev. 2005 Oct;26(6):833-76 [15901667.001]
  • [Cites] J Urol. 2005 Nov;174(5):2051-3 [16217392.001]
  • [Cites] CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30 [16514137.001]
  • [Cites] Cancer Res. 2006 Jun 1;66(11):5624-32 [16740699.001]
  • [Cites] Ann N Y Acad Sci. 2006 Nov;1089:1-13 [17261752.001]
  • [Cites] Regul Toxicol Pharmacol. 1999 Oct;30(2 Pt 1):156-66 [10536110.001]
  • [Cites] Prostate. 1999 Nov 1;41(3):203-7 [10517879.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):221-3 [10698486.001]
  • [Cites] Leuk Lymphoma. 2000 Mar;37(1-2):39-51 [10721768.001]
  • [Cites] Endocrinology. 2000 Sep;141(9):3471-7 [10965920.001]
  • [Cites] Mol Cell Endocrinol. 2000 Jun;164(1-2):109-16 [11026563.001]
  • [Cites] Endocrinology. 2001 Jan;142(1):359-69 [11145599.001]
  • [Cites] Endocr Rev. 2001 Jun;22(3):319-41 [11399747.001]
  • [Cites] J Cell Sci. 2001 Jun;114(Pt 11):1971-2 [11493633.001]
  • [Cites] Prostate. 1994;24(2):67-78 [7508622.001]
  • [Cites] J Androl. 1994 Mar-Apr;15(2):97-9 [8056642.001]
  • [Cites] Endocrinology. 1975 Oct;97(4):898-907 [1193012.001]
  • [Cites] Invest Urol. 1978 Nov;16(3):186-90 [711410.001]
  • [Cites] Endocrinology. 1979 May;104(5):1442-6 [86439.001]
  • [Cites] Gan. 1978 Dec;69(6):861-2 [750279.001]
  • [Cites] Invest Urol. 1979 Jul;17(1):3-8 [447483.001]
  • [Cites] Obstet Gynecol. 1980 Nov;56(5):537-42 [7432722.001]
  • [Cites] Int Rev Cytol. 1983;84:235-68 [6358105.001]
  • [Cites] Acta Endocrinol (Copenh). 1986 Jul;112(3):447-56 [3751459.001]
  • [Cites] J Urol. 1986 Nov;136(5):1136-40 [3773083.001]
  • [Cites] Teratog Carcinog Mutagen. 1987;7(4):411-22 [2442828.001]
  • [Cites] Endocr Rev. 1987 Aug;8(3):338-62 [3308446.001]
  • [Cites] Br J Cancer. 1988 Feb;57(2):216-8 [3358915.001]
  • [Cites] J Natl Cancer Inst. 1988 Sep 7;80(13):1045-53 [2457709.001]
  • [Cites] Prostate. 1989;15(2):195-210 [2678040.001]
  • [Cites] Prostate. 1990;17(1):19-30 [1696712.001]
  • [Cites] Biol Reprod. 1991 Aug;45(2):308-21 [1786296.001]
  • [Cites] Endocrinology. 1992 Jun;130(6):3703-14 [1597166.001]
  • [Cites] J Urol. 1993 Jun;149(6):1593-601 [8501817.001]
  • [Cites] Endocrinology. 1993 Jun;132(6):2342-50 [7684975.001]
  • [Cites] Endocrinology. 1993 Jun;132(6):2387-98 [8504743.001]
  • [Cites] Environ Health Perspect. 2005 Aug;113(8):926-33 [16079060.001]
  • [Cites] Endocrinology. 2005 Sep;146(9):4138-47 [15919749.001]
  • (PMID = 17123779.001).
  • [ISSN] 0890-6238
  • [Journal-full-title] Reproductive toxicology (Elmsford, N.Y.)
  • [ISO-abbreviation] Reprod. Toxicol.
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK040890; United States / NIEHS NIH HHS / ES / R21 ES012281; United States / NIEHS NIH HHS / ES / R01 ES015584; United States / NIEHS NIH HHS / ES / ES12281; United States / NIEHS NIH HHS / ES / P30 ES006096; United States / NIDDK NIH HHS / DK / DK40890
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Estrogens
  • [Number-of-references] 90
  • [Other-IDs] NLM/ NIHMS23013; NLM/ PMC1927084
  •  go-up   go-down


69. Nijs E, Callahan MJ, Taylor GA: Disorders of the pediatric pancreas: imaging features. Pediatr Radiol; 2005 Apr;35(4):358-73; quiz 457
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Familiarity with the range of normal appearance and the diseases that commonly affect this gland is important for the accurate and timely diagnosis of pancreatic disorders in the pediatric population.
  • Primary pancreatic neoplasms are rare in children and are divided into exocrine tumors such as pancreatoblastoma and adenocarcinoma and into endocrine or islet cell tumors.
  • [MeSH-major] Diagnostic Imaging. Pancreatic Diseases / diagnosis
  • [MeSH-minor] Adult. Child. Humans. Infant. Pancreas / abnormalities. Pancreas / anatomy & histology. Pancreatic Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • MedlinePlus Health Information. consumer health - Pancreatic Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15536562.001).
  • [ISSN] 0301-0449
  • [Journal-full-title] Pediatric radiology
  • [ISO-abbreviation] Pediatr Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 50
  •  go-up   go-down


70. Gatta G, Ciccolallo L, Kunkler I, Capocaccia R, Berrino F, Coleman MP, De Angelis R, Faivre J, Lutz JM, Martinez C, Möller T, Sankila R, EUROCARE Working Group: Survival from rare cancer in adults: a population-based study. Lancet Oncol; 2006 Feb;7(2):132-40
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • FINDINGS: Overall 5-year relative survival was good (ie, >65%) for placental choriocarcinoma (85.4% [95% CI 81.4-89.5]), thyroid medullary carcinoma (72.4% [69.2-75.5]), ovarian germ-cell cancer (73.0% [70.0-76.0]), lung carcinoid (70.1% [67.3-72.9]), and cervical adenocarcinoma (65.5% [64.3-66.6]); intermediate (ie, 35-65%) for testicular cancer at age 65 years or older (64.0% [59.3-68.7]), sarcoma of extremities (60.0% [58.9-61.2]), digestive-system endocrine cancers (55.6% [54.9-56.3]), anal squamous-cell carcinoma (53.1% [51.5-54.8]), and uterine sarcoma (43.5% [42.0-44.9]); low for carcinoma of adrenal-gland cortex (32.7% [28.3-37.2]) and bladder squamous-cell carcinoma (20.4% [18.8-22.0]); and poor for angiosarcoma of liver (6.4% [1.8-11.0]) and mesothelioma (4.7% [4.3-5.2]).
  • Survival significantly improved over time for ovarian germ-cell cancer, sarcomas of extremities, digestive-system endocrine tumours, anal squamous-cell carcinoma, and angiosarcoma of liver.

  • MedlinePlus Health Information. consumer health - Rare Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16455477.001).
  • [ISSN] 1470-2045
  • [Journal-full-title] The Lancet. Oncology
  • [ISO-abbreviation] Lancet Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


71. Ziółkowska E, Biedka M, Zyromska A, Makarewicz R: Psoriasis exacerbation after hormonotherapy in prostate cancer patient-Case report. Rep Pract Oncol Radiother; 2010;15(4):103-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Among systemic factors are endocrine and metabolic disturbances as well as many drugs.
  • A 57-year-old Caucasian man was admitted for curative radiation therapy of adenocarcinoma of the prostate after 3 months of initial hormonal therapy.
  • We decided to start the previously planned radiation therapy which included the prostate gland with 1.5 cm margin and provided for the total dose of 72 Gy in 36 fractions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24376933.001).
  • [ISSN] 1507-1367
  • [Journal-full-title] Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology
  • [ISO-abbreviation] Rep Pract Oncol Radiother
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Other-IDs] NLM/ PMC3863271
  • [Keywords] NOTNLM ; Hormonotherapy / Prostate cancer / Psoriasis
  •  go-up   go-down


72. Hines OJ, Reber HA: Pancreatic surgery. Curr Opin Gastroenterol; 2009 Sep;25(5):460-5
MedlinePlus Health Information. consumer health - Pancreatic Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RECENT FINDINGS: Obesity is an important risk factor for many diseases of the pancreas, including pancreatic adenocarcinoma.
  • Recent evidence suggests that obese patients with pancreatic cancer appear to have more advanced disease at the time of diagnosis and a worse outcome following resection.
  • Resection of pancreatic endocrine neoplasms is often appropriate, even in the face of metastatic disease.
  • For those dedicated to the study and treatment of this gland, several new advances help the clinician with treatment decisions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19550315.001).
  • [ISSN] 1531-7056
  • [Journal-full-title] Current opinion in gastroenterology
  • [ISO-abbreviation] Curr. Opin. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 22
  •  go-up   go-down


73. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W, European Thyroid Cancer Taskforce: European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol; 2006 Jun;154(6):787-803
Hazardous Substances Data Bank. THYROGLOBULIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Eur J Endocrinol. 2006 Aug;155(2):385
  • (PMID = 16728537.001).
  • [ISSN] 0804-4643
  • [Journal-full-title] European journal of endocrinology
  • [ISO-abbreviation] Eur. J. Endocrinol.
  • [Language] ENG
  • [Publication-type] Consensus Development Conference; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Autoantibodies; 0 / Iodine Radioisotopes; 9010-34-8 / Thyroglobulin
  • [Number-of-references] 116
  •  go-up   go-down


74. Corté H, Benoist S, Penna C: [Very late development of hepatic metastases]. J Chir (Paris); 2009 Aug;146(4):423-30
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / secondary. Endocrine Gland Neoplasms / secondary. Liver Neoplasms / secondary. Neoplasms, Second Primary. Rectal Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19766997.001).
  • [ISSN] 0021-7697
  • [Journal-full-title] Journal de chirurgie
  • [ISO-abbreviation] J Chir (Paris)
  • [Language] fre
  • [Publication-type] Case Reports; Clinical Conference; Comparative Study; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin
  •  go-up   go-down






Advertisement